#  @Borlaug_ Borlaug Borlaug posts on X about $dhr, $rgen, $tmo, $srt the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours. ### Engagements: [---] [#](/creator/twitter::1488524958032609284/interactions)  - [--] Week [-----] -79% - [--] Month [------] +4,659% - [--] Months [-----------] +3,540% - [--] Year [-----------] +69,172% ### Mentions: [--] [#](/creator/twitter::1488524958032609284/posts_active)  - [--] Months [---] +92% - [--] Year [---] +26% ### Followers: [-----] [#](/creator/twitter::1488524958032609284/followers)  - [--] Week [-----] -0.08% - [--] Month [-----] +0.51% - [--] Months [-----] +4.70% - [--] Year [-----] +28% ### CreatorRank: [---------] [#](/creator/twitter::1488524958032609284/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [cryptocurrencies](/list/cryptocurrencies) [technology brands](/list/technology-brands) [countries](/list/countries) [social networks](/list/social-networks) [celebrities](/list/celebrities) [exchanges](/list/exchanges) **Social topic influence** [$dhr](/topic/$dhr), [$rgen](/topic/$rgen), [$tmo](/topic/$tmo) #14, [$srt](/topic/$srt), [in the](/topic/in-the), [tools](/topic/tools), [$avtr](/topic/$avtr), [if you](/topic/if-you), [$ilmn](/topic/$ilmn), [$wst](/topic/$wst) **Top accounts mentioned or mentioned by** [@leveragedbunny](/creator/undefined) [@longvollllll](/creator/undefined) [@thenarrenschiff](/creator/undefined) [@zissoucapital](/creator/undefined) [@invesquotes](/creator/undefined) [@jerrycap](/creator/undefined) [@thelapurchaser](/creator/undefined) [@pythiar](/creator/undefined) [@cousingraig](/creator/undefined) [@petermantas](/creator/undefined) [@larryjamieson](/creator/undefined) [@sinstockpapi](/creator/undefined) [@noahpetey](/creator/undefined) [@comebackcap](/creator/undefined) [@riggedcapital](/creator/undefined) [@peterphan88](/creator/undefined) [@researchbyh](/creator/undefined) [@helapapi](/creator/undefined) [@compoundpapi](/creator/undefined) [@williscap](/creator/undefined) **Top assets mentioned** [Danaher Corporation (DHR)](/topic/$dhr) [Repligen, Corp. (RGEN)](/topic/$rgen) [Thermo Fisher Scientific Inc. (TMO)](/topic/$tmo) [Avantor, Inc. (AVTR)](/topic/$avtr) [Illumina, Inc. (ILMN)](/topic/$ilmn) [West Pharmaceutical Services Inc. (WST)](/topic/$wst) [Catalent Inc (CTLT)](/topic/$ctlt) [Bruker, Corp. (BRKR)](/topic/$brkr) [Charles River Laboratories Intl. Inc (CRL)](/topic/$crl) [BIO-TECHNE Corp (TECH)](/topic/$tech) [Iqvia Holdings Inc (IQV)](/topic/$iqv) [Stevanato Group S.p.A. (STVN)](/topic/$stvn) [Steris, PLC. (STE)](/topic/$ste) [Wat (WAT)](/topic/$wat) [10x Genomics, Inc. Class A Common Stock (TXG)](/topic/$txg) [Icon Plc (ICLR)](/topic/$iclr) [UnitedHealth Group (UNH)](/topic/$unh) [Abcam PLC (ABCM)](/topic/$abcm) [Laboratory Corp. of America Holdings (LH)](/topic/$lh) [Pacific Biosciences of California, Inc. (PACB)](/topic/$pacb) [Intuitive Surgical, Inc. (ISRG)](/topic/$isrg) [Eli Lilly and Company (LLY)](/topic/$lly) [Basilisk (BSX)](/topic/$bsx) [Revvity, Inc. (RVTY)](/topic/$rvty) [PROCEPT BioRobotics Corporation (PRCT)](/topic/$prct) [Align Technology, Inc. (ALGN)](/topic/$algn) [Medpace Holdings, Inc. Common Stock (MEDP)](/topic/$medp) [Olink Holding AB (publ) (OLK)](/topic/$olk) [Johnson & Johnson (JNJ)](/topic/$jnj) [Novo-Nordisk (NVO)](/topic/$nvo) [Rapid Micro Biosystems, Inc. (RPID)](/topic/$rpid) [Natera, Inc. Common Stock (NTRA)](/topic/$ntra) [Quest Diagnostics Inc (DGX)](/topic/$dgx) [Stryker Corporation (SYK)](/topic/$syk) [Zimmer Biomet Holdings Inc (ZBH)](/topic/$zbh) [BABB (BAX)](/topic/$bax) [Syneos Health, Inc. Class A Common Stock (SYNH)](/topic/$synh) [DexCom, Inc. (DXCM)](/topic/$dxcm) [Elevance Health Inc (ELV)](/topic/$elv) ### Top Social Posts Top posts by engagements in the last [--] hours "@Logos_LP Only a matter of time before someone takes on Sartorius and replicates Ambr" [X Link](https://x.com/Borlaug_/status/1572265571449962498) 2022-09-20T16:44Z [----] followers, [--] engagements "@Logos_LP @marketplunger1 Think about how amazingly theyre positioned. Small enough to get bought by larger CRO/a $DHR like $TMO for PPD and large enough to be an acquirer of the long tail of smaller peers and have it be meaningful to EPS in a way $IQV cant" [X Link](https://x.com/Borlaug_/status/1573292578212302848) 2022-09-23T12:45Z [----] followers, [--] engagements "@DiamondHandsDNA Ha this has been my bull thesis for the NT. Even as a standalone business facing COVID roll-off $DNA is so well-aligned with all the key players to win state/federal funding for testing. And $LH/ $DGX probably love it too" [X Link](https://x.com/Borlaug_/status/1581980922915999745) 2022-10-17T12:10Z [----] followers, [--] engagements "$PRCT could be having a monster couple of years ahead. I bet it eats $TFX's UroLift over time too" [X Link](https://x.com/Borlaug_/status/1611399046819618816) 2023-01-06T16:27Z [----] followers, [----] engagements "Added to $STE. Listened to call and have concluded that 10% down is stupid" [X Link](https://x.com/Borlaug_/status/1623773835622326274) 2023-02-09T20:00Z [----] followers, [---] engagements "Cowen on $AVTR - nothing new tbh" [X Link](https://x.com/Borlaug_/status/1633493344188874752) 2023-03-08T15:42Z [----] followers, [----] engagements "Via JEF for the $CRL $NOTV crowd:" [X Link](https://x.com/Borlaug_/status/1635616985953316864) 2023-03-14T12:20Z [----] followers, [----] engagements "While Cowen likes the current ( $TMO + analytical tools) trade JEF getting stoked about bioprocessing" [X Link](https://x.com/anyuser/status/1635639101318737922) 2023-03-14T13:48Z [----] followers, 20.5K engagements "$ILMN from an ISI investor survey. EVERYONE HATES THE GRAIL DEAL WAKE UP FRANCIS" [X Link](https://x.com/Borlaug_/status/1635997726050582535) 2023-03-15T13:33Z [----] followers, [---] engagements "$CRL $NOTV Society of Toxicology experts.LOL @ the activists. Looks like some preliminary R&D can be routed that effectively hasn't been but could still rule out certain drug candidates" [X Link](https://x.com/Borlaug_/status/1638190907001323521) 2023-03-21T14:48Z [----] followers, [----] engagements "$LH gobbling up all the US monkey supply. $CRL $NOTV really need the Cambodia thing to go well don't they" [X Link](https://x.com/Borlaug_/status/1638889580081610753) 2023-03-23T13:04Z [----] followers, [----] engagements "30% of BPH patients drop off drugs in the first [--] years. But they still don't get surgery. Why ERECTILE & EJACULATORY DYSFUNCTION. LOOK AT THIS NONSENSE. Would you ever take a chance of ED this high" [X Link](https://x.com/Borlaug_/status/1639249850238742532) 2023-03-24T12:56Z [----] followers, [----] engagements "The benefits aren't just for the patients: the actual time it takes to do the procedure is far faster than surgery. You save [--] minutes on average. This allows a hospital to do more surgery with the same amount of time. It is a doctor-enabling technology at high-volume centers" [X Link](https://x.com/Borlaug_/status/1639250714206654466) 2023-03-24T13:00Z [----] followers, [---] engagements "The treatment itself is covered by Medicare (50% of procedures) and most commercial payors cover it as well. Reimbursement compares favorably with $TFX's UroLift (higher even at [--] implants) and surgery" [X Link](https://x.com/Borlaug_/status/1639250912270233601) 2023-03-24T13:00Z [----] followers, [---] engagements "In the mid-2010's $TFX came to market with UroLift which was an implant-based system. No cuts. Data was excellent. Became a $400M product in short order. Except it wasn't until around [----] when data started showing that the implants don't last long" [X Link](https://x.com/Borlaug_/status/1639251095582281729) 2023-03-24T13:01Z [----] followers, [---] engagements "Longer term there is no reason $PRCT can't do $400M+ in consumables like $TFX did in [----] and mkt is growing 6%+. Adding back $100M in system revenue a mature profile would easily be $500M+ in revenue in [--] years - $3B at 6x sales. Roughly triple in a conservative scenario" [X Link](https://x.com/Borlaug_/status/1639251926020702209) 2023-03-24T13:04Z [----] followers, [---] engagements "Uh ohh is the R&D drought finally hitting the preclinical CROs next couple Qs Question remains. are these guys cutting preclin spend more than others are outsourcing it $CRL $NOTV" [X Link](https://x.com/Borlaug_/status/1640704601497165825) 2023-03-28T13:17Z [----] followers, [----] engagements "Lol $ILMN board recommends you let the board members keep their jobs. Shocker. Hopefully this Icahn situation scares them into doing their jobs properly even if they win" [X Link](https://x.com/Borlaug_/status/1641434663301332992) 2023-03-30T13:38Z [----] followers, [---] engagements "GUYS $PRCT STOPPED TURDING OMG ITS TIME" [X Link](https://x.com/Borlaug_/status/1641797289822789633) 2023-03-31T13:39Z [----] followers, [----] engagements "Results from an investor survey (N=146). $RGEN is a consensus long $TXG $PACB $ILMN are battleground stocks right now. Was surprised at how much more controversy there was in core tools vs growth tools. $WAT is everyone's fave short again" [X Link](https://x.com/Borlaug_/status/1644866493627215874) 2023-04-09T00:55Z [----] followers, [----] engagements "We back Is it funding o'clock $CRL" [X Link](https://x.com/Borlaug_/status/1645437956822278145) 2023-04-10T14:45Z [----] followers, [----] engagements "If the little guys think they need to add capacity this has to be pretty good for $DHR and $SRT/ $DIM given they're out in front for filtration specifically but obviously speaks to broader bioprocessing demand too" [X Link](https://x.com/Borlaug_/status/1645444486380519427) 2023-04-10T15:11Z [----] followers, [----] engagements "From a survey last week - med device procedures continue to improve (ortho highest priority $ZBH) while capex is tricky. $ISRG most exposed beds and imaging less so $SYK $HOLX" [X Link](https://x.com/Borlaug_/status/1645454793698058240) 2023-04-10T15:52Z [----] followers, [---] engagements "What a day for cloud cos this will be. CPI looks good/fine MS putting out a check that says optimizations are long-term great for the space and that we get re-accel in [----]. Also upgrading $CFLT and $MDB to overweight. Lot of good newsflow for the SW degens" [X Link](https://x.com/Borlaug_/status/1646136497001705473) 2023-04-12T13:01Z [----] followers, [----] engagements "More JEF pumping $ALGN" [X Link](https://x.com/Borlaug_/status/1646165142562848771) 2023-04-12T14:55Z [----] followers, [---] engagements "This. Wuxi is almost 100% single use(smaller max batch size) Samsung almost 100% stainless steel (just started mixing in single-use). Lonza just does everything the most. Catalent's only unique asset is fill-finish but the whole industry is starving for substance capacity so it doesn't matter" [X Link](https://x.com/Borlaug_/status/1648072622226153480) 2023-04-17T21:15Z [----] followers, [---] engagements "It was bad. Very bad. Organic orders down 36% lol $SRT $DHR Negative cross read for $DHR $AVTR $RGEN. Sartorius printed big miss result Negative cross read for $DHR $AVTR $RGEN. Sartorius printed big miss result" [X Link](https://x.com/Borlaug_/status/1649042101357756418) 2023-04-20T13:27Z [----] followers, 19.1K engagements "Trial starts seems data - pretty supportive of the idea that $ICLR and $IQV will be okay for a few years - you might get some backlog shrinkage but there's no reason to believe ph2/3 (where all the money is) falls off too meaningfully" [X Link](https://x.com/Borlaug_/status/1649118380085870595) 2023-04-20T18:30Z [----] followers, [----] engagements "$BSX used to tell you that their growth algo was VC + R&D + Tuck-ins to keep organic in the high-singles. Buying something bigger like $SWAV just proves wasn't a reliable system tbh. Much more fun to own the growth devices anyway" [X Link](https://x.com/Borlaug_/status/1649475725454450688) 2023-04-21T18:10Z [----] followers, [----] engagements "This looks pretty darn bearish for $A $WAT $BRKR" [X Link](https://x.com/Borlaug_/status/1650185205351628801) 2023-04-23T17:09Z [----] followers, [----] engagements "$SRT vs $RGEN growth history. Buyside allegedly thinks a miss is coming and Stephens thinks that's enough to drive upside" [X Link](https://x.com/Borlaug_/status/1650551970929815552) 2023-04-24T17:27Z [----] followers, [----] engagements "Finished a writeup on $AVTR (link in comments for obvious reasons). Found doing some of the extra work useful - the long case wasn't as simple as the multiple suggests (this is not a short-term trade). LMK thoughts pls thx" [X Link](https://x.com/Borlaug_/status/1650848456884334592) 2023-04-25T13:05Z [----] followers, [----] engagements "$DHR Numbers - as everyone's already said lower bioprocessing guide is rough. There's a big silver lining here - opportunity is being created if you can look past the next few quarters. This year could turn into a very easy comp in [----] for a high-growth space Bear thesis for bioprocessing names was always longer stocking impact than expected - this is the beginning of where it would be starting. Might create opportunities. I want $RGEN at mid-40x EPS. Bear thesis for bioprocessing names was always longer stocking impact than expected - this is the beginning of where it would be starting." [X Link](https://x.com/anyuser/status/1650852498100371456) 2023-04-25T13:21Z [----] followers, 36.5K engagements "$LH tightened up bottom of guide on a beat on both segments. Covance segment relevant for $CRL $IQV $ICLR since it is both preclinical and clinical CRO until they spin" [X Link](https://x.com/Borlaug_/status/1650855017576800256) 2023-04-25T13:31Z [----] followers, [----] engagements "JEF Thinks $MEDP results actually bode poorly for clinical CROs. beat driven by a large customer win but implications are bad for rest of year - don't think it changes anything for $IQV $ICLR" [X Link](https://x.com/Borlaug_/status/1650858374798405634) 2023-04-25T13:44Z [----] followers, [----] engagements "Think this got muzzled. link in bio if you want to learn about what's stopping $AVTR from being the next $TMO" [X Link](https://x.com/Borlaug_/status/1651248023635214337) 2023-04-26T15:33Z [----] followers, [----] engagements "$BAX solid Q" [X Link](https://x.com/Borlaug_/status/1651562561291137025) 2023-04-27T12:22Z [----] followers, [---] engagements "$AVTR organic beat vs guide leads to topline beat with worse covid headwinds than expected. Biopharma & adv mats down low singles HC & gov down mid singles. They made some margin oopsies so EPS in-line" [X Link](https://x.com/Borlaug_/status/1651931150997245952) 2023-04-28T12:47Z [----] followers, [--] engagements "Another shoe could be dropping. $IEX health/sci tech business is falling off a cliff sells a lot of analytical equipment inputs. JEF says super correlated to $WAT $A $DHR $TMO This looks pretty darn bearish for $A $WAT $BRKR https://t.co/DRZdTf4LVo This looks pretty darn bearish for $A $WAT $BRKR https://t.co/DRZdTf4LVo" [X Link](https://x.com/Borlaug_/status/1651944248483147777) 2023-04-28T13:39Z [----] followers, 16.6K engagements "Commentary from INTERPHEX suggests stocking doesn't go away until sometime in second half esp in fluid management. but the funding commentary backs pharma R&D spend pickup chart I posted last wedk. $DHR $AVTR $RGEN $SRT" [X Link](https://x.com/Borlaug_/status/1653032843914665985) 2023-05-01T13:45Z [----] followers, [----] engagements "Lol $RGEN bulls on drugs forecasting 10% above-mkt growth in out years and slapping 30% exit multiple for no reason to get to a PT with upside. $DIM / $SRT over this all day" [X Link](https://x.com/Borlaug_/status/1653043699062800384) 2023-05-01T14:28Z [----] followers, [----] engagements "@WTCM3 $DIM order book so useful for understanding visibility. at peak order numbers were like 1x next qtr revenue. How could you have real visibility With order books back to small you're relying on sales reps who rely on voice of customer. and that's what's changing rapidly" [X Link](https://x.com/Borlaug_/status/1653047201877184513) 2023-05-01T14:42Z [----] followers, [---] engagements "Just dropped part [--] of my bioprocessing primer. Link in bio for an overview of the trend driving long-term growth at $DHR $SRT $WST $RGEN and several others. Feedback always welcome. Will cover the outsourcing trend in a subsequent one" [X Link](https://x.com/anyuser/status/1654117535459966987) 2023-05-04T13:35Z [----] followers, 63K engagements "$BRKR another red hot quarter. no clue how this level of growth is sustainable even w/ new products for the whole end mkt" [X Link](https://x.com/Borlaug_/status/1654149253185298436) 2023-05-04T15:41Z [----] followers, [----] engagements "$SYNH getting bought. $43 a share is 12% premium 10x EBITDA" [X Link](https://x.com/Borlaug_/status/1656266427551170560) 2023-05-10T11:54Z [----] followers, [----] engagements "Hot take: this was actually a pretty crappy quarter at $CRL" [X Link](https://x.com/Borlaug_/status/1656638845058678784) 2023-05-11T12:34Z [----] followers, [----] engagements "New CFO could be a big deal for $AVTR depending on scope of what the CFO office controls over there" [X Link](https://x.com/Borlaug_/status/1658117894822060032) 2023-05-15T14:31Z [----] followers, [----] engagements "@LeveragedBunny Yeah in the case of $AVTR it really just matters how much influence the role has over M&A vs corp dev" [X Link](https://x.com/Borlaug_/status/1658125066570194944) 2023-05-15T14:59Z [----] followers, [---] engagements "@Calvsams Thank you Probably harder to find that data but if you listen to what $WST and $STVN say youre probably getting sufficient qualitative data since they basically own the market for delivery inputs together" [X Link](https://x.com/Borlaug_/status/1658503297702203394) 2023-05-16T16:02Z [----] followers, [--] engagements "JEF bullish on semicap due to govt incentives intensifying plus the existing trends: 1) Bigger chips 2) Trailing node demand 3) Increased transistor complexity. $AMAT $ASML et al" [X Link](https://x.com/Borlaug_/status/1659600974493933568) 2023-05-19T16:44Z [----] followers, [----] engagements "$CTLT has been fun today. Windley framing upside/downside and with the move today the skew is pretty balanced (I'd leave out the replacement scenario)" [X Link](https://x.com/Borlaug_/status/1659605101278011392) 2023-05-19T17:01Z [----] followers, [--] engagements "Guess if most of the GLP-1 market ends up going to oral LT that's pretty bad for $WST but good for whoever gets to manufacture orals ( $CTLT ) for them" [X Link](https://x.com/Borlaug_/status/1661056211461062682) 2023-05-23T17:07Z [----] followers, [----] engagements "@45thCap I think $WST has the market for the physical injectables and does CMO for one of them but whereas $CTLT just doing fill finish (which means if it goes oral they could win the substance + fill finish pretty easily)" [X Link](https://x.com/Borlaug_/status/1661062326794043393) 2023-05-23T17:31Z [----] followers, [---] engagements "Looks like it's already dropping. $A F2Q print was rough new guide has a weak second half baked in on pharma capital instrument weakness. Matters bc the other's aren't quite there and this one ends April" [X Link](https://x.com/Borlaug_/status/1661362471636959233) 2023-05-24T13:24Z [----] followers, [--] engagements "@VB4alpha @riddle245 Agreed but most of the new stuff that was benefitting bioprocessing was from emerging biopharma whereas this looks like big cap r&d is just optimizing/ not balling out on capex" [X Link](https://x.com/Borlaug_/status/1661386556999868430) 2023-05-24T14:59Z [----] followers, [---] engagements "@thecontracap @hcls24 @bucketshopcap Funding is the real headwind IMO. Fill finish always has excess capacity (otherwise your margins look like $Bax business that got bought) but they were also over earning. But you dont need all funding to come back just to normalize. Nowhere else to go in both parts" [X Link](https://x.com/Borlaug_/status/1662166597752979458) 2023-05-26T18:39Z [----] followers, [--] engagements "@peterphan88 @TheTipasa I feel like this thing has the potential to be like $ISRG in a lot of ways just grows like teens+ for way too long at a high multiple and everyone who has the guts to pay up wins" [X Link](https://x.com/Borlaug_/status/1662987019977478148) 2023-05-29T00:59Z [----] followers, [--] engagements "CapEx is getting worse in the space too. $ISRG $PRCT" [X Link](https://x.com/Borlaug_/status/1663526995572015104) 2023-05-30T12:45Z [----] followers, [----] engagements "$DXCM $PODD $TDNM Diabetes survey shows we still have a few years of runway for DD industry growth" [X Link](https://x.com/Borlaug_/status/1663527543012507648) 2023-05-30T12:47Z [----] followers, [----] engagements "Donaldson ( $DCI ) life sciences -13% in F3Q (thru April). 4Q has M&A in it. Cited softness in Disk Drive products more than offset sales growth in Food and Beverage. Good read for $A $WAT w/ the food exposure" [X Link](https://x.com/Borlaug_/status/1664270331631239168) 2023-06-01T13:59Z [----] followers, [--] engagements "This is literally making me rethink my lack of $RGEN position.assuming they get some share of the commercial process chain (even if its just filters especially if its columns) it could save their [----] numbers" [X Link](https://x.com/Borlaug_/status/1664277418537000960) 2023-06-01T14:27Z [----] followers, [----] engagements "@LeveragedBunny I think if $LLY $BIIB have the conviction youll start to see production ramp ahead of launch no" [X Link](https://x.com/Borlaug_/status/1664279493421449218) 2023-06-01T14:35Z [----] followers, [---] engagements "$UNH $HUM $ELV definitely going to benefit from this. conference commentary supporting it MS Survey points to utilization recovery slowing. commentary points to utilization going to "in-line" with COVID levels (was "above"). $BSX $STE $ISRG https://t.co/RdZc42gNWU MS Survey points to utilization recovery slowing. commentary points to utilization going to "in-line" with COVID levels (was "above"). $BSX $STE $ISRG https://t.co/RdZc42gNWU" [X Link](https://x.com/Borlaug_/status/1664648764504567809) 2023-06-02T15:02Z [----] followers, 13.5K engagements "The fact it cant happen until [----] is probably why the market is ignoring the stake tbh $BIO" [X Link](https://x.com/Borlaug_/status/1664658321834487810) 2023-06-02T15:40Z [----] followers, [----] engagements "$SBUX's Oleato finally made its way to Boston. Tried it at ASGCT and got addicted despite avoid getting coffee there for months. well played by Starby's" [X Link](https://x.com/Borlaug_/status/1666443926465552385) 2023-06-07T13:56Z [----] followers, [----] engagements "@pharmafather123 This would shut down the whole supply chain. Long $CTLT" [X Link](https://x.com/Borlaug_/status/1666964057541210113) 2023-06-09T00:22Z [----] followers, [--] engagements "Too little too late $ILMN" [X Link](https://x.com/Borlaug_/status/1667904112107696129) 2023-06-11T14:38Z [----] followers, [--] engagements "$ILMN By the weekend everything was settled. DeSouza would step down effective immediately and the board would begin a search for his successor. The company's GC Charles Dadswell will serve as interim CEO. $ILMN By the weekend everything was settled. DeSouza would step down effective immediately and the board would begin a search for his successor. The company's GC Charles Dadswell will serve as interim CEO. $ILMN" [X Link](https://x.com/Borlaug_/status/1667912257068494850) 2023-06-11T15:10Z [----] followers, [----] engagements "I'm tryna pull a Ross Gerber [---] and get myself that CEO seat at $ILMN. Value prop: I promise I will spin Grail. You're welcome" [X Link](https://x.com/Borlaug_/status/1668016943939346432) 2023-06-11T22:06Z [----] followers, [--] engagements "@marc_slans I own both but heavier in $DHR" [X Link](https://x.com/Borlaug_/status/1668095925615566852) 2023-06-12T03:20Z [----] followers, [--] engagements "$CTLT the cuts are getting smaller. $25M is 6% cut to FY23 EBITDA. Guessing this leads street to cut FY24 again as well" [X Link](https://x.com/Borlaug_/status/1668243626248269824) 2023-06-12T13:07Z [----] followers, [--] engagements "@LeveragedBunny 30x fwd like $MSFT pls thx" [X Link](https://x.com/Borlaug_/status/1668605143623913473) 2023-06-13T13:04Z [----] followers, [--] engagements "$CTLT Seems like most of the sell side stuck to their ratings but all of them raised price targets lol" [X Link](https://x.com/Borlaug_/status/1668624043233402881) 2023-06-13T14:19Z [----] followers, [--] engagements "Stephen's saying Alz bioprocessing TAM is $7B. Probably just a couple B's when you assume like a quarter of the patient population gets it but that's kinda all you need to get $DHR $RGEN etc. numbers looking good again next year with funding normalizing" [X Link](https://x.com/anyuser/status/1668713182486044673) 2023-06-13T20:13Z [----] followers, 16.1K engagements "@LeveragedBunny Yeah. I try to stay away from the portfolio device companies like $BSX but if you wanna be early you should totally dust off $SHC . Everyone thinks there is this crazy lawsuit tail risk and it just doesnt have real merit and the result is like 10x EBITDA" [X Link](https://x.com/Borlaug_/status/1668966775248109578) 2023-06-14T13:01Z [----] followers, [---] engagements "Got some questions about this - $RGEN says bioprocessing TAM is $22B (keep in mind some portion is clinical some commercial). This is somewhat misleading bc you can't take share from commercial processes really. Commercial probably just under half (super rough numbers - $500M biologics sales - 10% is COGS - 20% of COGS is BP consumables = 10B). Clinical is tricky too because once a process is in the clinic those tools don't change either" [X Link](https://x.com/Borlaug_/status/1668972529006911490) 2023-06-14T13:23Z [----] followers, [----] engagements "@TannerP03345759 @PythiaR So much of that not addressable any time soon by $ISRG. Like half alone is ortho. Then neuro skin cardio etc" [X Link](https://x.com/Borlaug_/status/1669360567646318592) 2023-06-15T15:05Z [----] followers, [---] engagements "BofA is dead to me. D/G'd my baby $EVO $EVT on a cyber attack from over a month ago :( (jk I love u Derik just a lil less now)" [X Link](https://x.com/Borlaug_/status/1669705436373688320) 2023-06-16T13:56Z [----] followers, [--] engagements "$BRKR Analyst day - LT guide up 100bps to 6%-8% organic. Not a huge move since buyside was expecting it" [X Link](https://x.com/Borlaug_/status/1669707902997655553) 2023-06-16T14:06Z [----] followers, [----] engagements "@CousinGraig $BRKR $A $WAT" [X Link](https://x.com/Borlaug_/status/1669723616634720261) 2023-06-16T15:08Z [----] followers, [---] engagements "@LongVollllll Or is it" [X Link](https://x.com/Borlaug_/status/1671138708576190464) 2023-06-20T12:51Z [----] followers, [----] engagements "@dividend_grow @LongVollllll You can be a fanboy and not own the stock if you're not too biased haha I'm waiting for $RGEN but own $DHR" [X Link](https://x.com/Borlaug_/status/1671143333647745024) 2023-06-20T13:09Z [----] followers, [---] engagements "Some thoughts on $SRT guide from Fri. 1) The new guide basically gets $DIM inline with $DHR $RGEN etc if you stack the growth back [--] or [--] years. 2) Funding environment is worse in EU/UK and also was a bigger beneficiary of the [----] explosion in funding. (cont'd)" [X Link](https://x.com/anyuser/status/1671146824248307715) 2023-06-20T13:23Z [----] followers, 28.4K engagements "@dividend_grow @LongVollllll Them too. I feel like ppl forget they're effectively the only other pure-play BP asset other than $RGEN" [X Link](https://x.com/Borlaug_/status/1671150848770990084) 2023-06-20T13:39Z [----] followers, [---] engagements "@LeveragedBunny Theyre all consumable heavy fwiw. I worry more about the other 80% of $AVTR now" [X Link](https://x.com/Borlaug_/status/1671156695199006721) 2023-06-20T14:03Z [----] followers, [---] engagements "Anyone following this NIH stuff $ILMN $TECH $ABCM $BRKR could become massive shorts if budget cut risk realizes" [X Link](https://x.com/anyuser/status/1671523968442945537) 2023-06-21T14:22Z [----] followers, 44.6K engagements "Disclosure: I was long $DHR/ $TMO the whole time but considering adding another name/more weight now. $RGEN so punchy but can manage w/ the weight" [X Link](https://x.com/Borlaug_/status/1671563111260618769) 2023-06-21T16:57Z [----] followers, [----] engagements "@hvntting Oh I'm not writing that off at all. $RGEN could theoretically have number upside potential w/ biosimilar launches and Alz especially relative to its smaller revenue footprint. Prob end up just going basket" [X Link](https://x.com/Borlaug_/status/1671570949722734592) 2023-06-21T17:29Z [----] followers, [---] engagements "@sidecarcap $DHR be showing signs of adopting this as well" [X Link](https://x.com/Borlaug_/status/1671588096347971600) 2023-06-21T18:40Z [----] followers, [----] engagements "Ayy $SHC gets it done in IL. +15%" [X Link](https://x.com/Borlaug_/status/1671891935739650049) 2023-06-22T14:44Z [----] followers, [----] engagements "$SRPT $CTLT LFG. CY24 just got de-risked big time" [X Link](https://x.com/Borlaug_/status/1671952214519103488) 2023-06-22T18:44Z [----] followers, [----] engagements "@SweatyEquities United would murder them in court if they tried tbh. Too many precedents of vertical integration already exist IMO" [X Link](https://x.com/Borlaug_/status/1673382616060538880) 2023-06-27T17:36Z [----] followers, [---] engagements "$ILMN sounds like it needs that extra 100bps of margin pretty badly 🧐 DNA sequencing giant #Illumina has begun to lay off 10% of its research and development team according to internal emails obtained and reviewed by STAT. https://t.co/YogVImOeLV DNA sequencing giant #Illumina has begun to lay off 10% of its research and development team according to internal emails obtained and reviewed by STAT. https://t.co/YogVImOeLV" [X Link](https://x.com/Borlaug_/status/1673470008205410304) 2023-06-26T23:15Z [----] followers, [----] engagements "At least pharmacy volumes probably tracking well as a read-through Haven't backtested that one though" [X Link](https://x.com/Borlaug_/status/1673696811444498432) 2023-06-27T14:16Z [----] followers, [--] engagements "Think selling off on $WBA commentary on COVID vax falling off a cliff which could lengthen stocking am I missing anything $DHR $TMO $RGEN all taking it $DHR $TMO Was there a downgrade here $DHR $TMO Was there a downgrade here" [X Link](https://x.com/Borlaug_/status/1673731918087720960) 2023-06-27T16:36Z [----] followers, 22.6K engagements "Looks like $TMO might be buying this thing. must be really going for it in clinical CRO biz. Makes sense because a lot of the smaller players ( $SYNH and smaller) are struggling to stay afloat. Casper probably seeing a huge opening as things normalize" [X Link](https://x.com/Borlaug_/status/1676572191284948992) 2023-07-05T12:42Z [----] followers, [----] engagements "A week old but posting here anyway. hospital survey from Evercore. $IHI / medtech is still the place to park it in healthcare this year regardless of how much I love tools over the long term. Sounds like a lot of it is fully-valued already however. Some upside in $DHR testing" [X Link](https://x.com/Borlaug_/status/1676574704352542723) 2023-07-05T12:52Z [----] followers, [----] engagements "$TMO Corevitas deal confirmed. 8.3x fwd sales of $110M growing low-singles. Immediately accretive by a few cents" [X Link](https://x.com/anyuser/status/1676937733552455681) 2023-07-06T12:54Z [----] followers, 14.3K engagements "@Deuceswild221 Another tricky one now. It's up 30% since I posted the thread on it even though they had that big placement miss. The medtech macro has been constantly improving all year but I'm struggling with how high the bar is for them this Q. Worried about a "beat" and selloff scenario" [X Link](https://x.com/Borlaug_/status/1678504491778187264) 2023-07-10T21:17Z [----] followers, [---] engagements "@CapsidCapital Evercore survey ticked up for capex as well fyi" [X Link](https://x.com/Borlaug_/status/1678505517231095808) 2023-07-11T00:50Z [----] followers, [---] engagements "Just published my latest. Lil primer about the omics companies like $ILMN $TXG $PACB $AKYA $TECH $OLK. Link in bio feedback welcome as usual" [X Link](https://x.com/anyuser/status/1678884083118624768) 2023-07-11T21:48Z [----] followers, 23.3K engagements "@blackjacket_v2 $A left out because it's a largecap portfolio of assets no other reason. $AKYA I'm lukewarm on tbh but looks cheap" [X Link](https://x.com/Borlaug_/status/1678969274658959360) 2023-07-12T04:42Z [----] followers, [---] engagements "@Goderguy Im just quoting Vijay here on total volume demand I had like 6%" [X Link](https://x.com/Borlaug_/status/1679157680571555844) 2023-07-12T16:08Z [----] followers, [---] engagements "$UNH got saved by lack of high-acuity care being needed in the Q. Slight MLR beat seems like they are investing the margins away in Optum to push growth right now. Great read-through for elective procedures less so for things like TAVR and cancer treatments" [X Link](https://x.com/Borlaug_/status/1679854416122216454) 2023-07-14T14:04Z [----] followers, [----] engagements "BofA's healthcare strategist did both a fund manager survey and 13f analysis - Thinks positioning is overweight medtech/facilities underweight tools/pharma/spec pharma neutral on everything else. Between $UNH MLR beat and positioning maybe the procedure beats won't be enough" [X Link](https://x.com/Borlaug_/status/1680920849753276418) 2023-07-17T12:42Z [----] followers, [--] engagements "RBC loves $AVTR $RGEN $BIO into the print. Think there's a world where $AVTR disappoints the least because it has the best geographical exposure in bioprocessing (aka US-heavy) and highest mix of shorter shelf-life consumables. Feels like the former doesn't get enough attention" [X Link](https://x.com/anyuser/status/1680923123250610176) 2023-07-17T12:51Z [----] followers, [----] engagements "@TheNarrenschiff Yeah and $CRL is actually cheap. they have such a low bar to clear "hey '24 numbers aren't effed because we fixed the monkey business" is enough for a re-rate. bioprocessing probably see a more mixed set of outcomes than last Q because each company is a different degree of" [X Link](https://x.com/Borlaug_/status/1680923793768734720) 2023-07-20T23:44Z [----] followers, [---] engagements "$CTLT probably smart to step away into this Q IMO. +23%ish since I wrote this up R/R is now a lot worse at 1:1 unless you think I'm being too chicken on my base case assumptions for FY24 (I was way above street but compensated w/ multiple). LT earnings power still pretty huge though" [X Link](https://x.com/Borlaug_/status/1680935241429417986) 2023-07-17T13:39Z [----] followers, [----] engagements "@BiasedRational Where else do you go for fill finish Its a relatively scarce asset $BAX is at capacity smaller players suck worse/ have even less trust or sample size. $TMO has some but I think people get over it. FDA broadly has been raising the bar too fwiw" [X Link](https://x.com/Borlaug_/status/1681327472724303872) 2023-07-18T15:38Z [----] followers, [--] engagements "$ABT device beat across the board $JNJ looks like a miss in hips/knees which is interesting. Surgery is still SO IN rn. Everybody go get surgery unless you wanna be uncool" [X Link](https://x.com/anyuser/status/1682014316222922754) 2023-07-20T13:07Z [----] followers, 10.9K engagements "@LongVollllll Maybe $ZBH and $SYK just took a boatload of share from a distracted spin story" [X Link](https://x.com/Borlaug_/status/1682016822860603394) 2023-07-20T13:17Z [----] followers, [---] engagements "@CapsidCapital Gonna get forced to own them all over again backdoored through $DHR lmao" [X Link](https://x.com/Borlaug_/status/1682035061154254850) 2023-07-24T17:20Z [----] followers, [---] engagements "$CTLT. is it stocking or are CDMOs just not replacing filters when they are supposed to 🧐" [X Link](https://x.com/Borlaug_/status/1682087160214593551) 2023-07-20T17:56Z [----] followers, [----] engagements "$SRT $DIM can't wait for this call. bioprocessing guide stays put pace of order declines moderated throughout the quarter. So good for the bottoming thesis in BP. BUT lab products are now getting worse. $DHR $RGEN guide cuts seem a lil more limited after this but $TMO/ $BRKR et all worth being careful on" [X Link](https://x.com/anyuser/status/1682374990186835969) 2023-07-21T13:00Z [----] followers, 23.7K engagements "Makes sense following $A commentary that big pharma is getting cheap because of the IRA" [X Link](https://x.com/Borlaug_/status/1682375195472871428) 2023-07-21T13:01Z [----] followers, [----] engagements "@DMckdani People have their money on $ABCM or $CTLT" [X Link](https://x.com/Borlaug_/status/1682403284370309122) 2023-07-21T14:52Z [----] followers, [---] engagements "@Paper1357 Lab supplies part is scary but Sartorius said a bunch of really encouraging stuff about bioprocessing market on the call that's got all the BP companies moving up. $AVTR also is the best-positioned geographically of all the tools/BP companies (most US lowest China) IMO. I might" [X Link](https://x.com/Borlaug_/status/1682405232221863937) 2023-07-21T19:57Z [----] followers, [---] engagements "1. Henning @researchbyh is criminally underfollowed and you're all going to jail. [--]. He's making a great point here that I don't think should get lost. $SRT is saying they expect ORDERS to recover in 2H. Not revenue. Don't plan on any exciting upside to numbers this year. My case for bioprocessing in June was/still is around the fact that 1) Tools is oversold broadly 2) bioprocessing was even deeper in the doghouse and 3)the market is going to have an easy time looking past this year coming out of 2Q earnings into the secular growth story that lives in 2024+. I still believe these to be true" [X Link](https://x.com/Borlaug_/status/1683444203404001280) 2023-07-24T11:49Z [----] followers, [----] engagements "@researchbyh $DHR and $RGEN numbers still have [----] downside IMO just not enough of it to make 3) stop mattering at this point. $AVTR may fare better due to better geography & short-life consumables assuming they don't just lose a bunch of share and make everyone sad" [X Link](https://x.com/Borlaug_/status/1683444564948918272) 2023-07-24T11:50Z [----] followers, [----] engagements "Feel like most of the space sells off if the China BPS thing is more China than BPS" [X Link](https://x.com/Borlaug_/status/1683811102776233984) 2023-07-25T12:07Z [----] followers, [----] engagements "@ROICinvestor I wanna say yes but underlying bp guide at Sartorius is lower than $DHR and $srt management seemed to show that they did a lot of work to get the visibility they had" [X Link](https://x.com/Borlaug_/status/1683816593636073474) 2023-07-25T12:28Z [----] followers, [--] engagements "$TMO was rough but let's not forget they didn't cut guide last Q. Was kinda scratching my head at that. missed opportunity to de-risk the rest of the year understandably. Looks like miss was mostly LSS. TMO also has a big APAC exposure and called out Chiner" [X Link](https://x.com/anyuser/status/1684162943108145154) 2023-07-26T11:25Z [----] followers, 16.9K engagements "@peter_mantas I struggle w this. Obviously it looks awful for $CTLT but who tf wouldn't say that after this sh*t" [X Link](https://x.com/Borlaug_/status/1684551441610948608) 2023-07-27T13:08Z [----] followers, [----] engagements "Hah I think you're reading the comment too negatively to $LFCR . I think this absolutely gives them some well-deserved attention from prospective customers. What I'm saying is that in a world where supply is at or below demand for FF $CTLT still has a reasonable shot at filling theirs" [X Link](https://x.com/Borlaug_/status/1684557511205031937) 2023-07-27T13:33Z [----] followers, [---] engagements "$AVTR print was pretty awful. Joins $MTD in the tools print graveyard. Biopharma and Advanced Tech/Materials both down high singles" [X Link](https://x.com/Borlaug_/status/1684891920198246400) 2023-07-28T11:41Z [----] followers, [----] engagements "$IQV trimming 1% off of guide implies 4Q of 3% ish below consensus on rev with some margin mismatching. Could be TAS as Book-to-bill staying high is very encouraging. Large cCROs might have been the easiest trade in largecap life sciences this year" [X Link](https://x.com/Borlaug_/status/1686349274374647808) 2023-08-01T12:12Z [----] followers, [----] engagements "I thought superconductor was what they called the top 10% of ppl driving the $UNP trains" [X Link](https://x.com/Borlaug_/status/1686372104952815616) 2023-08-01T13:43Z [----] followers, [----] engagements "$RGEN guide for base biz goes from +4-8% to minus 5-10%. Monster cut. Hopefully a gift for the LT crowd but theyre also the likely seller on a print like this at an institutional level" [X Link](https://x.com/Borlaug_/status/1686707546772385792) 2023-08-02T11:56Z [----] followers, [----] engagements "Guess I'm not adding to my position today" [X Link](https://x.com/Borlaug_/status/1686732261943640064) 2023-08-02T13:34Z [----] followers, [----] engagements "Couldn't make myself post earnings updates for all the tools not named $DHR $TMO this week because I hate repeating myself. Was literally the same quarter for everyone with very few exceptions. China was bad academia holding up industrials mixed etc. Seems the new question is large pharma spending and how long that stays muted" [X Link](https://x.com/anyuser/status/1687447177231020032) 2023-08-04T12:55Z [----] followers, 12.8K engagements "@LeveragedBunny Yeah my entire bioprocessing call is predicated on people positioning too short and then being forced to look past [----]. You can now make the same argument for $unh" [X Link](https://x.com/Borlaug_/status/1687452140317360128) 2023-08-04T13:15Z [----] followers, [--] engagements "This vid makes me wanna manufacture drugs ASAP. JESSE WE NEED TO COOK $RGEN #Vimeo https://vimeo.com/787412981 https://vimeo.com/787412981" [X Link](https://x.com/Borlaug_/status/1688858129348403200) 2023-08-08T10:22Z [----] followers, [----] engagements "Funding still coming back - we've now strung [--] "up" months together. Have seen conflicting data from other sell side firms but JEF seems to put actual effort into curating their screens. $DHR $TMO getting hungry to eat these dollars" [X Link](https://x.com/anyuser/status/1688911027289923585) 2023-08-08T13:52Z [----] followers, 12.4K engagements "Big for science $CRL Charles Monkey has successfully mitigated the logistical challenges of the current NHP supply constraints. Raises the lower end of the guidance. Important datapoint for early stage biological research $CRL https://t.co/JvSXBwYuzZ Charles Monkey has successfully mitigated the logistical challenges of the current NHP supply constraints. Raises the lower end of the guidance. Important datapoint for early stage biological research $CRL https://t.co/JvSXBwYuzZ" [X Link](https://x.com/Borlaug_/status/1689261074434965504) 2023-08-09T13:03Z [----] followers, [----] engagements "I know I joke about us being back a lot but I'm starting to think we're not actually back until $SYNH puts up a book-to-bill greater than [--]. Would tell you that the fragmented tail of cCROs are starting to see enough demand that $IQV $TMO $ICLR etc don't service Funding still coming back - we've now strung [--] "up" months together. Have seen conflicting data from other sell side firms but JEF seems to put actual effort into curating their screens. $DHR $TMO getting hungry to eat these dollars https://t.co/kx1MJFGtho Funding still coming back - we've now strung [--] "up" months together. Have seen" [X Link](https://x.com/Borlaug_/status/1689272715553693697) 2023-08-09T13:49Z [----] followers, [----] engagements "On '24 numbers (P/S since they all burn dollars): $BLFS: 5x w/o biz assuming 0% growth on '23 $MXCT: 6-7x (w/ a high-80s/90% GM) 30% growth $CLPT: 5x '24 estimates 20% growth $MRVI: 14x EV/'24 EBITDA assumes 4% sales growth and much lower margins than historical" [X Link](https://x.com/Borlaug_/status/1689932232541065217) 2023-08-11T09:30Z [----] followers, [----] engagements "Obviously you need to believe numbers. but for $BLFS and $MRVI the out-year growth assumption for good multiples looks like a joke. $MXCT $CLPT are both supported by drugs launching ( $VRTX has a drug that lifts $MXCT growth by like 10% if it does what MS is modeling)" [X Link](https://x.com/Borlaug_/status/1689932672808685568) 2023-08-11T09:32Z [----] followers, [----] engagements "Most of large cap looks fully valued except for CROs and MCOs. $UNH $CRL $IQV $ICLR all cheap on multiples as does $EVT if you normalize a bit. Could argue $UNH and the other MCOs have some TV risk w/ GLP1s" [X Link](https://x.com/Borlaug_/status/1689933442744557568) 2023-08-11T09:35Z [----] followers, [----] engagements "@mghanco If you believe the street estimates for both $IQV and $MEDP out to [----] they are equally cheap if you adjust for growth" [X Link](https://x.com/Borlaug_/status/1689954072604909568) 2023-08-11T10:57Z [----] followers, [---] engagements "Finally got done w/ my poast (@Larryjamieson_ got me addicted to this spelling) on $RGEN talking about why I think it outgrows $DHR / $SRT / $TMO in bioprocessing while being a lot less expensive than meets the eye. You know where to find it. Haters gonna short anyway" [X Link](https://x.com/anyuser/status/1689991232418652161) 2023-08-11T13:24Z [----] followers, 14.5K engagements "Fair bit of contrast between MCO and Tools analyst takes on $NVO $LLY obesity drugs. Both are optimistic but both probably can't right in the short-term. Left is BofA explaining why the insurance burden won't be huge to $UNH $CI $ELV etc because there are levers the MCOs (esp. those w/ PBMs) can pull to slow the rate at which they cover these drugs for obesity while they align plan pricing to the costs. Right is Stephens quantifying what the benefit of these drugs to $WST would be if 18% of all obese (all levels of severity) US adults 45+ were on it by [----] in a base case. That's a lot of" [X Link](https://x.com/anyuser/status/1691453625837780992) 2023-08-15T14:15Z [----] followers, 14K engagements "@peter_mantas Actually scratch what I said. The molecule itself is "small" (not complex) but still delivered via mammalian cell. Totally gonna be a complex/biologics mfg process at scale" [X Link](https://x.com/Borlaug_/status/1695102279957819896) 2023-08-25T15:54Z [----] followers, [---] engagements "$DHR for $ABCM is solid strategically IMO. I think a lot of people always thought $TECH would be the way Danaher gets into antibody production. Maybe takes some of the floor out from under their multiple. Speaking of multiple. 32x EBITDA is steep" [X Link](https://x.com/anyuser/status/1696143262136914379) 2023-08-28T12:50Z [----] followers, 10.6K engagements "@RAMCOCAPITAL @PythiaR Overlap is super small. The $TECH team (about half of company is direct compare) is mostly ex Danaher and built theirs to not overlap as well. So if theres an issue it's gonna be a little less direct but I'd be surprised to see it" [X Link](https://x.com/Borlaug_/status/1696145763561078819) 2023-08-28T13:00Z [----] followers, [---] engagements "@sinstockpapi @ComebackCap More about the t2 population which should shrink in theory (assuming mass adoption). I think $DXCM does fine for the next few years but the terminal value is definitely impacted for both" [X Link](https://x.com/Borlaug_/status/1696553063929024623) 2023-08-29T15:59Z [----] followers, [--] engagements "I think $CTLT sandbagged the guide tbh" [X Link](https://x.com/Borlaug_/status/1696706294227292404) 2023-08-30T02:07Z [----] followers, [----] engagements "@astridwilde1 $STVN if you think $WST is in that category" [X Link](https://x.com/Borlaug_/status/1698856352532013229) 2023-09-05T00:31Z [----] followers, [---] engagements "$ILMN New CEO looks like a pragmatic fit coming from $A . Probably some more risk to topline numbers this year but considering refreshing the case on profitability post GRAIL alone" [X Link](https://x.com/Borlaug_/status/1699024023374397451) 2023-09-05T11:37Z [----] followers, [----] engagements "@ZissouCapital It looks like mostly pens tbh. Not sure how much you need high end Nexa if I'm right" [X Link](https://x.com/Borlaug_/status/1699131008665194815) 2023-09-05T18:42Z [----] followers, [---] engagements "@ZissouCapital Bottom line for me is that it's insane ppl are paying more for $WST than $STVN on '24 numbers. More rev upside margin upside etc for a 10% discount if you believe this is all gonna be injectable for a few years" [X Link](https://x.com/Borlaug_/status/1699133859336532154) 2023-09-05T18:54Z [----] followers, [---] engagements "@LongVollllll I just dont know if anyone is gonna buy a word these companies say at MS. What even got cheap" [X Link](https://x.com/Borlaug_/status/1699402875904950512) 2023-09-06T12:43Z [----] followers, [---] engagements "@sinstockpapi @Invesquotes None of them are perfectly sturdy IMO but $STVN if you believe injectables will be the most viable for [--] years" [X Link](https://x.com/Borlaug_/status/1699456391138656446) 2023-09-06T16:15Z [----] followers, [----] engagements "@HeLaPapi @sinstockpapi @Invesquotes I think they missed the wave with the big ones but are trying to win all the pipeline products" [X Link](https://x.com/Borlaug_/status/1699481452662993097) 2023-09-06T17:55Z [----] followers, [---] engagements "@HeLaPapi @hoosier_to @riceforthought @sinstockpapi @Invesquotes Kinda misses the point. you have to get diagnosed to get the GLPs for t2beetus so ofc you're gonna get scripted a CGM too since they run through the same channel. The real concern is what happens when ppl are getting GLP for obesity and many stop converting to the beetus" [X Link](https://x.com/Borlaug_/status/1699482014666149891) 2023-09-06T17:57Z [----] followers, [---] engagements "@SriniKartik @HeLaPapi @hoosier_to @riceforthought @sinstockpapi @Invesquotes Depends I suppose. Do you stay on the drugs and endure the side effects forever or do you try to switch to the gym I think the consumer angle is going to be fascinating if waves are made" [X Link](https://x.com/Borlaug_/status/1699739683960267044) 2023-09-07T11:01Z [----] followers, [--] engagements "@JerryCap @y2duggan @KathleenCa84658 We have preventative measures for obesity. $TDOC acquired one and it was an excellent short. Sam Im sorry you dont approve of how large pharmaceutical companies are trying to deal with the unsolved obesity problem 🙃" [X Link](https://x.com/Borlaug_/status/1700201014492635262) 2023-09-08T17:34Z [----] followers, [---] engagements "@PythiaR They sounded bad this week on bp" [X Link](https://x.com/Borlaug_/status/1700220587774267537) 2023-09-08T18:52Z [----] followers, [----] engagements "@valuebug @pekwat $IQV and $ICLR in clinical (more stable through cycle) $CRL and $EVT in pre-clinical (slightly more funding macro exposure)" [X Link](https://x.com/Borlaug_/status/1701243210696138867) 2023-09-11T14:36Z [----] followers, [---] engagements "@TheNarrenschiff Glad it reads as intended 😤" [X Link](https://x.com/Borlaug_/status/1701690805956579400) 2023-09-12T20:14Z [----] followers, [---] engagements "Based on the reactions I've heard from ppl talking to them at conferences the last couple of weeks and the contents of my prior tweet about how gene therapies are progressing way too slowly it's starting to seem likely $RGEN takes another guide cut next Q. Management might be getting blindsided on the slowness in gene therapy progression ( $CYRX release and $TECH AD have nuggets reinforcing this) after focusing intensely on figuring out what their exposures are to small biopharma broadly (via CDMOs) and navigating China forecast. CFO "retirement" doesn't help. Given exposure could be up to a" [X Link](https://x.com/anyuser/status/1701692624795558218) 2023-09-12T20:21Z [----] followers, 26.3K engagements "@TheNarrenschiff This sounds like it doesnt go up and to the right. Are we compounding multiple contraction" [X Link](https://x.com/Borlaug_/status/1721673691195408803) 2023-11-06T23:39Z [----] followers, [---] engagements "Is there a FAANG in life sciences Yes. It's called TRDS. Because they trade like them. For now. $TMO $RGEN $DHR $SRT" [X Link](https://x.com/anyuser/status/1724487732385214533) 2023-11-14T18:01Z [----] followers, 44.2K engagements "The $XBI didnt bottom unless biotwitter has finally learned the difference between a research institute and a company" [X Link](https://x.com/Borlaug_/status/1726742035569299780) 2023-11-20T23:19Z [----] followers, [----] engagements "Felt like I had a lot more to be thankful for this year than most. Pretty awesome feeling. Happy Thanksgiving fam" [X Link](https://x.com/Borlaug_/status/1727895007170863349) 2023-11-24T03:40Z [----] followers, [---] engagements "Happy $UNH day to those who celebrate" [X Link](https://x.com/Borlaug_/status/1729846220217094269) 2023-11-29T12:54Z [----] followers, [----] engagements "@callerycap Ill throw a venture capitalist at you" [X Link](https://x.com/Borlaug_/status/1735117292654997561) 2023-12-14T01:59Z [----] followers, [---] engagements "@JerryCap Imagine getting hit with a tariff on an input you cant switch away from because you specified a Chinese supplier in your FDA filing lmao" [X Link](https://x.com/Borlaug_/status/1740010881378041949) 2023-12-27T14:04Z [----] followers, [---] engagements "@princetongb Yeah I dont like paying for rent in dollar spot ETFs. Doesnt feel secure enough" [X Link](https://x.com/anyuser/status/1743101830488281433) 2024-01-05T02:47Z [--] followers, [---] engagements "@valuebug @rev_cap @WallStCynic Healthcare component is mostly healthcare wages which were inflated by temp labor" [X Link](https://x.com/Borlaug_/status/1746201166231351576) 2024-01-13T16:02Z [----] followers, [---] engagements "@peterphan88 @peter_mantas @LionelHutz_Esq It's a video game company actually" [X Link](https://x.com/Borlaug_/status/1750673052071825509) 2024-01-26T00:12Z [----] followers, [--] engagements "Same. Ignoring stuff that doesn't trade at a large FCF yield because it isn't a "value stock" is silly. Value guys I've met do this (stay in low P/E) because they believe you can't forecast out years reliably so they assume it can't be done and pass on tons of excellent businesses. They also like the idea that low P/E has downside protection which is also proven false when P/E compresses even more than they think is fair. No excuse to rely so hard on this when you're a long/short fund and can just hedge multiple risks out. The reality is that even if you think one can't forecast growth the" [X Link](https://x.com/anyuser/status/1755592748294439171) 2024-02-08T14:01Z [----] followers, 61.4K engagements "Agree but don't think that's really what is at the heart of the debate. It's about terminal value. Value guys buying cigar butts can't get paid on multiple if the market is only becoming more discerning/opinionated on terminal value which isn't really moving around much for their universe" [X Link](https://x.com/Borlaug_/status/1755667331580064149) 2024-02-08T18:58Z [----] followers, [---] engagements "Bill Gates wishes he thought of this during his Microsoft hypebeast days" [X Link](https://x.com/Borlaug_/status/1760366620692648067) 2024-02-21T18:11Z [----] followers, [----] engagements "What's the highest market cap you've ever seen a therapeutics company get to without a drug in phase [--] or commercial" [X Link](https://x.com/Borlaug_/status/1760764807945572640) 2024-02-22T20:33Z [----] followers, [----] engagements "@TheNarrenschiff Whos the lucky one today" [X Link](https://x.com/Borlaug_/status/1762865617542033471) 2024-02-28T15:41Z [----] followers, [---] engagements "@MihaiDoho @ftr_investors @EricFlaningam @DisruptorStocks @FedexSTi @ronjonbSaaS @LogicalThesis @SteadyCompound @GeneInvesting @FromValue @StockSavvyShay Needs more monkey prison" [X Link](https://x.com/Borlaug_/status/1763548485918372083) 2024-03-01T12:54Z [----] followers, [---] engagements "@MihaiDoho @ftr_investors @EricFlaningam @DisruptorStocks @FedexSTi @ronjonbSaaS @LogicalThesis @SteadyCompound @GeneInvesting @FromValue @StockSavvyShay I will die on this hill. And so will all the monkeys at $35k+ a pop" [X Link](https://x.com/Borlaug_/status/1763551540604698641) 2024-03-01T13:07Z [----] followers, [--] engagements "Long pharma services" [X Link](https://x.com/anyuser/status/1765182317520167097) 2024-03-06T01:07Z [----] followers, 15.6K engagements "@BeachedCapital None tbh" [X Link](https://x.com/Borlaug_/status/1765197804236857585) 2024-03-06T02:08Z [----] followers, [---] engagements "@NeoKJ2505 CRL LH NOTV in that order" [X Link](https://x.com/Borlaug_/status/1765202192988783009) 2024-03-06T02:26Z [----] followers, [---] engagements "It's really not subjective. The illiquid stuff is on the balance sheet marked at the last round valuation. LT investments is 137M ST is 120M of which some is probably Sernova and EXAI which ties closely to my [---]. Do you have a view on one of the privates being much bigger in the future" [X Link](https://x.com/Borlaug_/status/1768669322782597574) 2024-03-15T16:03Z [----] followers, [---] engagements "@SexyLikeMeiosis Because what could go wrong if you just make the bioreactor bigger" [X Link](https://x.com/Borlaug_/status/1770842171974811940) 2024-03-21T15:57Z [----] followers, [----] engagements "@FelixSchreibe13 @peter_mantas Was talking about the last 4/6 trains. Saw in transcript old CEO said end of year implying they hit the brakes or something" [X Link](https://x.com/Borlaug_/status/1771172097131212973) 2024-03-22T13:48Z [----] followers, [--] engagements "@WallStCynic @crazyjoedavola_ I am outraged You said number go up" [X Link](https://x.com/Borlaug_/status/1777869647196434681) 2024-04-10T01:22Z [----] followers, [---] engagements "@LaissezFaire416 Just threaten to squat" [X Link](https://x.com/Borlaug_/status/1778524098488061996) 2024-04-11T20:42Z [----] followers, [--] engagements "That's new. if true kind of a big deal/paradigm shift vs the last 5-7 years" [X Link](https://x.com/Borlaug_/status/1780313789893660900) 2024-04-16T19:14Z [----] followers, [----] engagements "@B6203107361179 hahahahahahah wtf is this" [X Link](https://x.com/Borlaug_/status/1782738337037468038) 2024-04-23T11:48Z [----] followers, [---] engagements "@TheLAPurchaser Dude yes. Monkey prisons. LFG" [X Link](https://x.com/Borlaug_/status/1783573055513518523) 2024-04-25T19:05Z [----] followers, [---] engagements "@TheLAPurchaser Agree. Right now still pretty crowded short. think they beat on mfg this Q too" [X Link](https://x.com/Borlaug_/status/1783575490239824244) 2024-04-25T19:15Z [----] followers, [---] engagements "@Goderguy @TheLAPurchaser Discovery chemistry is a big overlap between the two as well. Lead times on all that is 3-6 mo also iirc" [X Link](https://x.com/Borlaug_/status/1784042531686088733) 2024-04-27T02:11Z [----] followers, [---] engagements "@LaissezFaire416 Fintwit will do anything to avoid being forced to compound lmao" [X Link](https://x.com/Borlaug_/status/1791568741718729199) 2024-05-17T20:37Z [----] followers, [--] engagements "Candidly I am devastated at what happened today. Justice was not served. Politics should never come before the truth. My PM should have given my short rec its day in court but was ignored. And its not because of my atrocious hit rate" [X Link](https://x.com/Borlaug_/status/1796359315428970524) 2024-05-31T01:53Z [----] followers, [---] engagements "Did anyone else notice X take the mute option off the For You feed Give it back" [X Link](https://x.com/Borlaug_/status/1796367898971091234) 2024-05-31T02:27Z [----] followers, [----] engagements "@PetramcoC Dont love the TAS business but its gonna be more interesting when they re-launch their software w Salesforce later this year. Do love the trial business but have preferred ICON most of the year. Chuckie is most dislocated though" [X Link](https://x.com/Borlaug_/status/1798665629857370164) 2024-06-06T10:37Z [----] followers, [---] engagements "It's a little silly how much confidence investors put behind big tools companies but avoid big CROs on macro despite the same drivers. I keep hearing pricing as a risk but then they raise price every year and take share at the same time. Valuation disparity still nuts" [X Link](https://x.com/anyuser/status/1798703748585529552) 2024-06-06T13:09Z [----] followers, [----] engagements "@LongVollllll They should have gone out BEFORE ppl realized HC AI is all bs" [X Link](https://x.com/Borlaug_/status/1802002019248373868) 2024-06-15T15:35Z [----] followers, [---] engagements "@TwistBioscience Centrifuge (duh)" [X Link](https://x.com/Borlaug_/status/1811435262305615982) 2024-07-11T16:19Z [----] followers, [--] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@Borlaug_ BorlaugBorlaug posts on X about $dhr, $rgen, $tmo, $srt the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.
Social category influence stocks finance cryptocurrencies technology brands countries social networks celebrities exchanges
Social topic influence $dhr, $rgen, $tmo #14, $srt, in the, tools, $avtr, if you, $ilmn, $wst
Top accounts mentioned or mentioned by @leveragedbunny @longvollllll @thenarrenschiff @zissoucapital @invesquotes @jerrycap @thelapurchaser @pythiar @cousingraig @petermantas @larryjamieson @sinstockpapi @noahpetey @comebackcap @riggedcapital @peterphan88 @researchbyh @helapapi @compoundpapi @williscap
Top assets mentioned Danaher Corporation (DHR) Repligen, Corp. (RGEN) Thermo Fisher Scientific Inc. (TMO) Avantor, Inc. (AVTR) Illumina, Inc. (ILMN) West Pharmaceutical Services Inc. (WST) Catalent Inc (CTLT) Bruker, Corp. (BRKR) Charles River Laboratories Intl. Inc (CRL) BIO-TECHNE Corp (TECH) Iqvia Holdings Inc (IQV) Stevanato Group S.p.A. (STVN) Steris, PLC. (STE) Wat (WAT) 10x Genomics, Inc. Class A Common Stock (TXG) Icon Plc (ICLR) UnitedHealth Group (UNH) Abcam PLC (ABCM) Laboratory Corp. of America Holdings (LH) Pacific Biosciences of California, Inc. (PACB) Intuitive Surgical, Inc. (ISRG) Eli Lilly and Company (LLY) Basilisk (BSX) Revvity, Inc. (RVTY) PROCEPT BioRobotics Corporation (PRCT) Align Technology, Inc. (ALGN) Medpace Holdings, Inc. Common Stock (MEDP) Olink Holding AB (publ) (OLK) Johnson & Johnson (JNJ) Novo-Nordisk (NVO) Rapid Micro Biosystems, Inc. (RPID) Natera, Inc. Common Stock (NTRA) Quest Diagnostics Inc (DGX) Stryker Corporation (SYK) Zimmer Biomet Holdings Inc (ZBH) BABB (BAX) Syneos Health, Inc. Class A Common Stock (SYNH) DexCom, Inc. (DXCM) Elevance Health Inc (ELV)
Top posts by engagements in the last [--] hours
"@Logos_LP Only a matter of time before someone takes on Sartorius and replicates Ambr"
X Link 2022-09-20T16:44Z [----] followers, [--] engagements
"@Logos_LP @marketplunger1 Think about how amazingly theyre positioned. Small enough to get bought by larger CRO/a $DHR like $TMO for PPD and large enough to be an acquirer of the long tail of smaller peers and have it be meaningful to EPS in a way $IQV cant"
X Link 2022-09-23T12:45Z [----] followers, [--] engagements
"@DiamondHandsDNA Ha this has been my bull thesis for the NT. Even as a standalone business facing COVID roll-off $DNA is so well-aligned with all the key players to win state/federal funding for testing. And $LH/ $DGX probably love it too"
X Link 2022-10-17T12:10Z [----] followers, [--] engagements
"$PRCT could be having a monster couple of years ahead. I bet it eats $TFX's UroLift over time too"
X Link 2023-01-06T16:27Z [----] followers, [----] engagements
"Added to $STE. Listened to call and have concluded that 10% down is stupid"
X Link 2023-02-09T20:00Z [----] followers, [---] engagements
"Cowen on $AVTR - nothing new tbh"
X Link 2023-03-08T15:42Z [----] followers, [----] engagements
"Via JEF for the $CRL $NOTV crowd:"
X Link 2023-03-14T12:20Z [----] followers, [----] engagements
"While Cowen likes the current ( $TMO + analytical tools) trade JEF getting stoked about bioprocessing"
X Link 2023-03-14T13:48Z [----] followers, 20.5K engagements
"$ILMN from an ISI investor survey. EVERYONE HATES THE GRAIL DEAL WAKE UP FRANCIS"
X Link 2023-03-15T13:33Z [----] followers, [---] engagements
"$CRL $NOTV Society of Toxicology experts.LOL @ the activists. Looks like some preliminary R&D can be routed that effectively hasn't been but could still rule out certain drug candidates"
X Link 2023-03-21T14:48Z [----] followers, [----] engagements
"$LH gobbling up all the US monkey supply. $CRL $NOTV really need the Cambodia thing to go well don't they"
X Link 2023-03-23T13:04Z [----] followers, [----] engagements
"30% of BPH patients drop off drugs in the first [--] years. But they still don't get surgery. Why ERECTILE & EJACULATORY DYSFUNCTION. LOOK AT THIS NONSENSE. Would you ever take a chance of ED this high"
X Link 2023-03-24T12:56Z [----] followers, [----] engagements
"The benefits aren't just for the patients: the actual time it takes to do the procedure is far faster than surgery. You save [--] minutes on average. This allows a hospital to do more surgery with the same amount of time. It is a doctor-enabling technology at high-volume centers"
X Link 2023-03-24T13:00Z [----] followers, [---] engagements
"The treatment itself is covered by Medicare (50% of procedures) and most commercial payors cover it as well. Reimbursement compares favorably with $TFX's UroLift (higher even at [--] implants) and surgery"
X Link 2023-03-24T13:00Z [----] followers, [---] engagements
"In the mid-2010's $TFX came to market with UroLift which was an implant-based system. No cuts. Data was excellent. Became a $400M product in short order. Except it wasn't until around [----] when data started showing that the implants don't last long"
X Link 2023-03-24T13:01Z [----] followers, [---] engagements
"Longer term there is no reason $PRCT can't do $400M+ in consumables like $TFX did in [----] and mkt is growing 6%+. Adding back $100M in system revenue a mature profile would easily be $500M+ in revenue in [--] years - $3B at 6x sales. Roughly triple in a conservative scenario"
X Link 2023-03-24T13:04Z [----] followers, [---] engagements
"Uh ohh is the R&D drought finally hitting the preclinical CROs next couple Qs Question remains. are these guys cutting preclin spend more than others are outsourcing it $CRL $NOTV"
X Link 2023-03-28T13:17Z [----] followers, [----] engagements
"Lol $ILMN board recommends you let the board members keep their jobs. Shocker. Hopefully this Icahn situation scares them into doing their jobs properly even if they win"
X Link 2023-03-30T13:38Z [----] followers, [---] engagements
"GUYS $PRCT STOPPED TURDING OMG ITS TIME"
X Link 2023-03-31T13:39Z [----] followers, [----] engagements
"Results from an investor survey (N=146). $RGEN is a consensus long $TXG $PACB $ILMN are battleground stocks right now. Was surprised at how much more controversy there was in core tools vs growth tools. $WAT is everyone's fave short again"
X Link 2023-04-09T00:55Z [----] followers, [----] engagements
"We back Is it funding o'clock $CRL"
X Link 2023-04-10T14:45Z [----] followers, [----] engagements
"If the little guys think they need to add capacity this has to be pretty good for $DHR and $SRT/ $DIM given they're out in front for filtration specifically but obviously speaks to broader bioprocessing demand too"
X Link 2023-04-10T15:11Z [----] followers, [----] engagements
"From a survey last week - med device procedures continue to improve (ortho highest priority $ZBH) while capex is tricky. $ISRG most exposed beds and imaging less so $SYK $HOLX"
X Link 2023-04-10T15:52Z [----] followers, [---] engagements
"What a day for cloud cos this will be. CPI looks good/fine MS putting out a check that says optimizations are long-term great for the space and that we get re-accel in [----]. Also upgrading $CFLT and $MDB to overweight. Lot of good newsflow for the SW degens"
X Link 2023-04-12T13:01Z [----] followers, [----] engagements
"More JEF pumping $ALGN"
X Link 2023-04-12T14:55Z [----] followers, [---] engagements
"This. Wuxi is almost 100% single use(smaller max batch size) Samsung almost 100% stainless steel (just started mixing in single-use). Lonza just does everything the most. Catalent's only unique asset is fill-finish but the whole industry is starving for substance capacity so it doesn't matter"
X Link 2023-04-17T21:15Z [----] followers, [---] engagements
"It was bad. Very bad. Organic orders down 36% lol $SRT $DHR Negative cross read for $DHR $AVTR $RGEN. Sartorius printed big miss result Negative cross read for $DHR $AVTR $RGEN. Sartorius printed big miss result"
X Link 2023-04-20T13:27Z [----] followers, 19.1K engagements
"Trial starts seems data - pretty supportive of the idea that $ICLR and $IQV will be okay for a few years - you might get some backlog shrinkage but there's no reason to believe ph2/3 (where all the money is) falls off too meaningfully"
X Link 2023-04-20T18:30Z [----] followers, [----] engagements
"$BSX used to tell you that their growth algo was VC + R&D + Tuck-ins to keep organic in the high-singles. Buying something bigger like $SWAV just proves wasn't a reliable system tbh. Much more fun to own the growth devices anyway"
X Link 2023-04-21T18:10Z [----] followers, [----] engagements
"This looks pretty darn bearish for $A $WAT $BRKR"
X Link 2023-04-23T17:09Z [----] followers, [----] engagements
"$SRT vs $RGEN growth history. Buyside allegedly thinks a miss is coming and Stephens thinks that's enough to drive upside"
X Link 2023-04-24T17:27Z [----] followers, [----] engagements
"Finished a writeup on $AVTR (link in comments for obvious reasons). Found doing some of the extra work useful - the long case wasn't as simple as the multiple suggests (this is not a short-term trade). LMK thoughts pls thx"
X Link 2023-04-25T13:05Z [----] followers, [----] engagements
"$DHR Numbers - as everyone's already said lower bioprocessing guide is rough. There's a big silver lining here - opportunity is being created if you can look past the next few quarters. This year could turn into a very easy comp in [----] for a high-growth space Bear thesis for bioprocessing names was always longer stocking impact than expected - this is the beginning of where it would be starting. Might create opportunities. I want $RGEN at mid-40x EPS. Bear thesis for bioprocessing names was always longer stocking impact than expected - this is the beginning of where it would be starting."
X Link 2023-04-25T13:21Z [----] followers, 36.5K engagements
"$LH tightened up bottom of guide on a beat on both segments. Covance segment relevant for $CRL $IQV $ICLR since it is both preclinical and clinical CRO until they spin"
X Link 2023-04-25T13:31Z [----] followers, [----] engagements
"JEF Thinks $MEDP results actually bode poorly for clinical CROs. beat driven by a large customer win but implications are bad for rest of year - don't think it changes anything for $IQV $ICLR"
X Link 2023-04-25T13:44Z [----] followers, [----] engagements
"Think this got muzzled. link in bio if you want to learn about what's stopping $AVTR from being the next $TMO"
X Link 2023-04-26T15:33Z [----] followers, [----] engagements
"$BAX solid Q"
X Link 2023-04-27T12:22Z [----] followers, [---] engagements
"$AVTR organic beat vs guide leads to topline beat with worse covid headwinds than expected. Biopharma & adv mats down low singles HC & gov down mid singles. They made some margin oopsies so EPS in-line"
X Link 2023-04-28T12:47Z [----] followers, [--] engagements
"Another shoe could be dropping. $IEX health/sci tech business is falling off a cliff sells a lot of analytical equipment inputs. JEF says super correlated to $WAT $A $DHR $TMO This looks pretty darn bearish for $A $WAT $BRKR https://t.co/DRZdTf4LVo This looks pretty darn bearish for $A $WAT $BRKR https://t.co/DRZdTf4LVo"
X Link 2023-04-28T13:39Z [----] followers, 16.6K engagements
"Commentary from INTERPHEX suggests stocking doesn't go away until sometime in second half esp in fluid management. but the funding commentary backs pharma R&D spend pickup chart I posted last wedk. $DHR $AVTR $RGEN $SRT"
X Link 2023-05-01T13:45Z [----] followers, [----] engagements
"Lol $RGEN bulls on drugs forecasting 10% above-mkt growth in out years and slapping 30% exit multiple for no reason to get to a PT with upside. $DIM / $SRT over this all day"
X Link 2023-05-01T14:28Z [----] followers, [----] engagements
"@WTCM3 $DIM order book so useful for understanding visibility. at peak order numbers were like 1x next qtr revenue. How could you have real visibility With order books back to small you're relying on sales reps who rely on voice of customer. and that's what's changing rapidly"
X Link 2023-05-01T14:42Z [----] followers, [---] engagements
"Just dropped part [--] of my bioprocessing primer. Link in bio for an overview of the trend driving long-term growth at $DHR $SRT $WST $RGEN and several others. Feedback always welcome. Will cover the outsourcing trend in a subsequent one"
X Link 2023-05-04T13:35Z [----] followers, 63K engagements
"$BRKR another red hot quarter. no clue how this level of growth is sustainable even w/ new products for the whole end mkt"
X Link 2023-05-04T15:41Z [----] followers, [----] engagements
"$SYNH getting bought. $43 a share is 12% premium 10x EBITDA"
X Link 2023-05-10T11:54Z [----] followers, [----] engagements
"Hot take: this was actually a pretty crappy quarter at $CRL"
X Link 2023-05-11T12:34Z [----] followers, [----] engagements
"New CFO could be a big deal for $AVTR depending on scope of what the CFO office controls over there"
X Link 2023-05-15T14:31Z [----] followers, [----] engagements
"@LeveragedBunny Yeah in the case of $AVTR it really just matters how much influence the role has over M&A vs corp dev"
X Link 2023-05-15T14:59Z [----] followers, [---] engagements
"@Calvsams Thank you Probably harder to find that data but if you listen to what $WST and $STVN say youre probably getting sufficient qualitative data since they basically own the market for delivery inputs together"
X Link 2023-05-16T16:02Z [----] followers, [--] engagements
"JEF bullish on semicap due to govt incentives intensifying plus the existing trends: 1) Bigger chips 2) Trailing node demand 3) Increased transistor complexity. $AMAT $ASML et al"
X Link 2023-05-19T16:44Z [----] followers, [----] engagements
"$CTLT has been fun today. Windley framing upside/downside and with the move today the skew is pretty balanced (I'd leave out the replacement scenario)"
X Link 2023-05-19T17:01Z [----] followers, [--] engagements
"Guess if most of the GLP-1 market ends up going to oral LT that's pretty bad for $WST but good for whoever gets to manufacture orals ( $CTLT ) for them"
X Link 2023-05-23T17:07Z [----] followers, [----] engagements
"@45thCap I think $WST has the market for the physical injectables and does CMO for one of them but whereas $CTLT just doing fill finish (which means if it goes oral they could win the substance + fill finish pretty easily)"
X Link 2023-05-23T17:31Z [----] followers, [---] engagements
"Looks like it's already dropping. $A F2Q print was rough new guide has a weak second half baked in on pharma capital instrument weakness. Matters bc the other's aren't quite there and this one ends April"
X Link 2023-05-24T13:24Z [----] followers, [--] engagements
"@VB4alpha @riddle245 Agreed but most of the new stuff that was benefitting bioprocessing was from emerging biopharma whereas this looks like big cap r&d is just optimizing/ not balling out on capex"
X Link 2023-05-24T14:59Z [----] followers, [---] engagements
"@thecontracap @hcls24 @bucketshopcap Funding is the real headwind IMO. Fill finish always has excess capacity (otherwise your margins look like $Bax business that got bought) but they were also over earning. But you dont need all funding to come back just to normalize. Nowhere else to go in both parts"
X Link 2023-05-26T18:39Z [----] followers, [--] engagements
"@peterphan88 @TheTipasa I feel like this thing has the potential to be like $ISRG in a lot of ways just grows like teens+ for way too long at a high multiple and everyone who has the guts to pay up wins"
X Link 2023-05-29T00:59Z [----] followers, [--] engagements
"CapEx is getting worse in the space too. $ISRG $PRCT"
X Link 2023-05-30T12:45Z [----] followers, [----] engagements
"$DXCM $PODD $TDNM Diabetes survey shows we still have a few years of runway for DD industry growth"
X Link 2023-05-30T12:47Z [----] followers, [----] engagements
"Donaldson ( $DCI ) life sciences -13% in F3Q (thru April). 4Q has M&A in it. Cited softness in Disk Drive products more than offset sales growth in Food and Beverage. Good read for $A $WAT w/ the food exposure"
X Link 2023-06-01T13:59Z [----] followers, [--] engagements
"This is literally making me rethink my lack of $RGEN position.assuming they get some share of the commercial process chain (even if its just filters especially if its columns) it could save their [----] numbers"
X Link 2023-06-01T14:27Z [----] followers, [----] engagements
"@LeveragedBunny I think if $LLY $BIIB have the conviction youll start to see production ramp ahead of launch no"
X Link 2023-06-01T14:35Z [----] followers, [---] engagements
"$UNH $HUM $ELV definitely going to benefit from this. conference commentary supporting it MS Survey points to utilization recovery slowing. commentary points to utilization going to "in-line" with COVID levels (was "above"). $BSX $STE $ISRG https://t.co/RdZc42gNWU MS Survey points to utilization recovery slowing. commentary points to utilization going to "in-line" with COVID levels (was "above"). $BSX $STE $ISRG https://t.co/RdZc42gNWU"
X Link 2023-06-02T15:02Z [----] followers, 13.5K engagements
"The fact it cant happen until [----] is probably why the market is ignoring the stake tbh $BIO"
X Link 2023-06-02T15:40Z [----] followers, [----] engagements
"$SBUX's Oleato finally made its way to Boston. Tried it at ASGCT and got addicted despite avoid getting coffee there for months. well played by Starby's"
X Link 2023-06-07T13:56Z [----] followers, [----] engagements
"@pharmafather123 This would shut down the whole supply chain. Long $CTLT"
X Link 2023-06-09T00:22Z [----] followers, [--] engagements
"Too little too late $ILMN"
X Link 2023-06-11T14:38Z [----] followers, [--] engagements
"$ILMN By the weekend everything was settled. DeSouza would step down effective immediately and the board would begin a search for his successor. The company's GC Charles Dadswell will serve as interim CEO. $ILMN By the weekend everything was settled. DeSouza would step down effective immediately and the board would begin a search for his successor. The company's GC Charles Dadswell will serve as interim CEO. $ILMN"
X Link 2023-06-11T15:10Z [----] followers, [----] engagements
"I'm tryna pull a Ross Gerber [---] and get myself that CEO seat at $ILMN. Value prop: I promise I will spin Grail. You're welcome"
X Link 2023-06-11T22:06Z [----] followers, [--] engagements
"@marc_slans I own both but heavier in $DHR"
X Link 2023-06-12T03:20Z [----] followers, [--] engagements
"$CTLT the cuts are getting smaller. $25M is 6% cut to FY23 EBITDA. Guessing this leads street to cut FY24 again as well"
X Link 2023-06-12T13:07Z [----] followers, [--] engagements
"@LeveragedBunny 30x fwd like $MSFT pls thx"
X Link 2023-06-13T13:04Z [----] followers, [--] engagements
"$CTLT Seems like most of the sell side stuck to their ratings but all of them raised price targets lol"
X Link 2023-06-13T14:19Z [----] followers, [--] engagements
"Stephen's saying Alz bioprocessing TAM is $7B. Probably just a couple B's when you assume like a quarter of the patient population gets it but that's kinda all you need to get $DHR $RGEN etc. numbers looking good again next year with funding normalizing"
X Link 2023-06-13T20:13Z [----] followers, 16.1K engagements
"@LeveragedBunny Yeah. I try to stay away from the portfolio device companies like $BSX but if you wanna be early you should totally dust off $SHC . Everyone thinks there is this crazy lawsuit tail risk and it just doesnt have real merit and the result is like 10x EBITDA"
X Link 2023-06-14T13:01Z [----] followers, [---] engagements
"Got some questions about this - $RGEN says bioprocessing TAM is $22B (keep in mind some portion is clinical some commercial). This is somewhat misleading bc you can't take share from commercial processes really. Commercial probably just under half (super rough numbers - $500M biologics sales - 10% is COGS - 20% of COGS is BP consumables = 10B). Clinical is tricky too because once a process is in the clinic those tools don't change either"
X Link 2023-06-14T13:23Z [----] followers, [----] engagements
"@TannerP03345759 @PythiaR So much of that not addressable any time soon by $ISRG. Like half alone is ortho. Then neuro skin cardio etc"
X Link 2023-06-15T15:05Z [----] followers, [---] engagements
"BofA is dead to me. D/G'd my baby $EVO $EVT on a cyber attack from over a month ago :( (jk I love u Derik just a lil less now)"
X Link 2023-06-16T13:56Z [----] followers, [--] engagements
"$BRKR Analyst day - LT guide up 100bps to 6%-8% organic. Not a huge move since buyside was expecting it"
X Link 2023-06-16T14:06Z [----] followers, [----] engagements
"@CousinGraig $BRKR $A $WAT"
X Link 2023-06-16T15:08Z [----] followers, [---] engagements
"@LongVollllll Or is it"
X Link 2023-06-20T12:51Z [----] followers, [----] engagements
"@dividend_grow @LongVollllll You can be a fanboy and not own the stock if you're not too biased haha I'm waiting for $RGEN but own $DHR"
X Link 2023-06-20T13:09Z [----] followers, [---] engagements
"Some thoughts on $SRT guide from Fri. 1) The new guide basically gets $DIM inline with $DHR $RGEN etc if you stack the growth back [--] or [--] years. 2) Funding environment is worse in EU/UK and also was a bigger beneficiary of the [----] explosion in funding. (cont'd)"
X Link 2023-06-20T13:23Z [----] followers, 28.4K engagements
"@dividend_grow @LongVollllll Them too. I feel like ppl forget they're effectively the only other pure-play BP asset other than $RGEN"
X Link 2023-06-20T13:39Z [----] followers, [---] engagements
"@LeveragedBunny Theyre all consumable heavy fwiw. I worry more about the other 80% of $AVTR now"
X Link 2023-06-20T14:03Z [----] followers, [---] engagements
"Anyone following this NIH stuff $ILMN $TECH $ABCM $BRKR could become massive shorts if budget cut risk realizes"
X Link 2023-06-21T14:22Z [----] followers, 44.6K engagements
"Disclosure: I was long $DHR/ $TMO the whole time but considering adding another name/more weight now. $RGEN so punchy but can manage w/ the weight"
X Link 2023-06-21T16:57Z [----] followers, [----] engagements
"@hvntting Oh I'm not writing that off at all. $RGEN could theoretically have number upside potential w/ biosimilar launches and Alz especially relative to its smaller revenue footprint. Prob end up just going basket"
X Link 2023-06-21T17:29Z [----] followers, [---] engagements
"@sidecarcap $DHR be showing signs of adopting this as well"
X Link 2023-06-21T18:40Z [----] followers, [----] engagements
"Ayy $SHC gets it done in IL. +15%"
X Link 2023-06-22T14:44Z [----] followers, [----] engagements
"$SRPT $CTLT LFG. CY24 just got de-risked big time"
X Link 2023-06-22T18:44Z [----] followers, [----] engagements
"@SweatyEquities United would murder them in court if they tried tbh. Too many precedents of vertical integration already exist IMO"
X Link 2023-06-27T17:36Z [----] followers, [---] engagements
"$ILMN sounds like it needs that extra 100bps of margin pretty badly 🧐 DNA sequencing giant #Illumina has begun to lay off 10% of its research and development team according to internal emails obtained and reviewed by STAT. https://t.co/YogVImOeLV DNA sequencing giant #Illumina has begun to lay off 10% of its research and development team according to internal emails obtained and reviewed by STAT. https://t.co/YogVImOeLV"
X Link 2023-06-26T23:15Z [----] followers, [----] engagements
"At least pharmacy volumes probably tracking well as a read-through Haven't backtested that one though"
X Link 2023-06-27T14:16Z [----] followers, [--] engagements
"Think selling off on $WBA commentary on COVID vax falling off a cliff which could lengthen stocking am I missing anything $DHR $TMO $RGEN all taking it $DHR $TMO Was there a downgrade here $DHR $TMO Was there a downgrade here"
X Link 2023-06-27T16:36Z [----] followers, 22.6K engagements
"Looks like $TMO might be buying this thing. must be really going for it in clinical CRO biz. Makes sense because a lot of the smaller players ( $SYNH and smaller) are struggling to stay afloat. Casper probably seeing a huge opening as things normalize"
X Link 2023-07-05T12:42Z [----] followers, [----] engagements
"A week old but posting here anyway. hospital survey from Evercore. $IHI / medtech is still the place to park it in healthcare this year regardless of how much I love tools over the long term. Sounds like a lot of it is fully-valued already however. Some upside in $DHR testing"
X Link 2023-07-05T12:52Z [----] followers, [----] engagements
"$TMO Corevitas deal confirmed. 8.3x fwd sales of $110M growing low-singles. Immediately accretive by a few cents"
X Link 2023-07-06T12:54Z [----] followers, 14.3K engagements
"@Deuceswild221 Another tricky one now. It's up 30% since I posted the thread on it even though they had that big placement miss. The medtech macro has been constantly improving all year but I'm struggling with how high the bar is for them this Q. Worried about a "beat" and selloff scenario"
X Link 2023-07-10T21:17Z [----] followers, [---] engagements
"@CapsidCapital Evercore survey ticked up for capex as well fyi"
X Link 2023-07-11T00:50Z [----] followers, [---] engagements
"Just published my latest. Lil primer about the omics companies like $ILMN $TXG $PACB $AKYA $TECH $OLK. Link in bio feedback welcome as usual"
X Link 2023-07-11T21:48Z [----] followers, 23.3K engagements
"@blackjacket_v2 $A left out because it's a largecap portfolio of assets no other reason. $AKYA I'm lukewarm on tbh but looks cheap"
X Link 2023-07-12T04:42Z [----] followers, [---] engagements
"@Goderguy Im just quoting Vijay here on total volume demand I had like 6%"
X Link 2023-07-12T16:08Z [----] followers, [---] engagements
"$UNH got saved by lack of high-acuity care being needed in the Q. Slight MLR beat seems like they are investing the margins away in Optum to push growth right now. Great read-through for elective procedures less so for things like TAVR and cancer treatments"
X Link 2023-07-14T14:04Z [----] followers, [----] engagements
"BofA's healthcare strategist did both a fund manager survey and 13f analysis - Thinks positioning is overweight medtech/facilities underweight tools/pharma/spec pharma neutral on everything else. Between $UNH MLR beat and positioning maybe the procedure beats won't be enough"
X Link 2023-07-17T12:42Z [----] followers, [--] engagements
"RBC loves $AVTR $RGEN $BIO into the print. Think there's a world where $AVTR disappoints the least because it has the best geographical exposure in bioprocessing (aka US-heavy) and highest mix of shorter shelf-life consumables. Feels like the former doesn't get enough attention"
X Link 2023-07-17T12:51Z [----] followers, [----] engagements
"@TheNarrenschiff Yeah and $CRL is actually cheap. they have such a low bar to clear "hey '24 numbers aren't effed because we fixed the monkey business" is enough for a re-rate. bioprocessing probably see a more mixed set of outcomes than last Q because each company is a different degree of"
X Link 2023-07-20T23:44Z [----] followers, [---] engagements
"$CTLT probably smart to step away into this Q IMO. +23%ish since I wrote this up R/R is now a lot worse at 1:1 unless you think I'm being too chicken on my base case assumptions for FY24 (I was way above street but compensated w/ multiple). LT earnings power still pretty huge though"
X Link 2023-07-17T13:39Z [----] followers, [----] engagements
"@BiasedRational Where else do you go for fill finish Its a relatively scarce asset $BAX is at capacity smaller players suck worse/ have even less trust or sample size. $TMO has some but I think people get over it. FDA broadly has been raising the bar too fwiw"
X Link 2023-07-18T15:38Z [----] followers, [--] engagements
"$ABT device beat across the board $JNJ looks like a miss in hips/knees which is interesting. Surgery is still SO IN rn. Everybody go get surgery unless you wanna be uncool"
X Link 2023-07-20T13:07Z [----] followers, 10.9K engagements
"@LongVollllll Maybe $ZBH and $SYK just took a boatload of share from a distracted spin story"
X Link 2023-07-20T13:17Z [----] followers, [---] engagements
"@CapsidCapital Gonna get forced to own them all over again backdoored through $DHR lmao"
X Link 2023-07-24T17:20Z [----] followers, [---] engagements
"$CTLT. is it stocking or are CDMOs just not replacing filters when they are supposed to 🧐"
X Link 2023-07-20T17:56Z [----] followers, [----] engagements
"$SRT $DIM can't wait for this call. bioprocessing guide stays put pace of order declines moderated throughout the quarter. So good for the bottoming thesis in BP. BUT lab products are now getting worse. $DHR $RGEN guide cuts seem a lil more limited after this but $TMO/ $BRKR et all worth being careful on"
X Link 2023-07-21T13:00Z [----] followers, 23.7K engagements
"Makes sense following $A commentary that big pharma is getting cheap because of the IRA"
X Link 2023-07-21T13:01Z [----] followers, [----] engagements
"@DMckdani People have their money on $ABCM or $CTLT"
X Link 2023-07-21T14:52Z [----] followers, [---] engagements
"@Paper1357 Lab supplies part is scary but Sartorius said a bunch of really encouraging stuff about bioprocessing market on the call that's got all the BP companies moving up. $AVTR also is the best-positioned geographically of all the tools/BP companies (most US lowest China) IMO. I might"
X Link 2023-07-21T19:57Z [----] followers, [---] engagements
"1. Henning @researchbyh is criminally underfollowed and you're all going to jail. [--]. He's making a great point here that I don't think should get lost. $SRT is saying they expect ORDERS to recover in 2H. Not revenue. Don't plan on any exciting upside to numbers this year. My case for bioprocessing in June was/still is around the fact that 1) Tools is oversold broadly 2) bioprocessing was even deeper in the doghouse and 3)the market is going to have an easy time looking past this year coming out of 2Q earnings into the secular growth story that lives in 2024+. I still believe these to be true"
X Link 2023-07-24T11:49Z [----] followers, [----] engagements
"@researchbyh $DHR and $RGEN numbers still have [----] downside IMO just not enough of it to make 3) stop mattering at this point. $AVTR may fare better due to better geography & short-life consumables assuming they don't just lose a bunch of share and make everyone sad"
X Link 2023-07-24T11:50Z [----] followers, [----] engagements
"Feel like most of the space sells off if the China BPS thing is more China than BPS"
X Link 2023-07-25T12:07Z [----] followers, [----] engagements
"@ROICinvestor I wanna say yes but underlying bp guide at Sartorius is lower than $DHR and $srt management seemed to show that they did a lot of work to get the visibility they had"
X Link 2023-07-25T12:28Z [----] followers, [--] engagements
"$TMO was rough but let's not forget they didn't cut guide last Q. Was kinda scratching my head at that. missed opportunity to de-risk the rest of the year understandably. Looks like miss was mostly LSS. TMO also has a big APAC exposure and called out Chiner"
X Link 2023-07-26T11:25Z [----] followers, 16.9K engagements
"@peter_mantas I struggle w this. Obviously it looks awful for $CTLT but who tf wouldn't say that after this sh*t"
X Link 2023-07-27T13:08Z [----] followers, [----] engagements
"Hah I think you're reading the comment too negatively to $LFCR . I think this absolutely gives them some well-deserved attention from prospective customers. What I'm saying is that in a world where supply is at or below demand for FF $CTLT still has a reasonable shot at filling theirs"
X Link 2023-07-27T13:33Z [----] followers, [---] engagements
"$AVTR print was pretty awful. Joins $MTD in the tools print graveyard. Biopharma and Advanced Tech/Materials both down high singles"
X Link 2023-07-28T11:41Z [----] followers, [----] engagements
"$IQV trimming 1% off of guide implies 4Q of 3% ish below consensus on rev with some margin mismatching. Could be TAS as Book-to-bill staying high is very encouraging. Large cCROs might have been the easiest trade in largecap life sciences this year"
X Link 2023-08-01T12:12Z [----] followers, [----] engagements
"I thought superconductor was what they called the top 10% of ppl driving the $UNP trains"
X Link 2023-08-01T13:43Z [----] followers, [----] engagements
"$RGEN guide for base biz goes from +4-8% to minus 5-10%. Monster cut. Hopefully a gift for the LT crowd but theyre also the likely seller on a print like this at an institutional level"
X Link 2023-08-02T11:56Z [----] followers, [----] engagements
"Guess I'm not adding to my position today"
X Link 2023-08-02T13:34Z [----] followers, [----] engagements
"Couldn't make myself post earnings updates for all the tools not named $DHR $TMO this week because I hate repeating myself. Was literally the same quarter for everyone with very few exceptions. China was bad academia holding up industrials mixed etc. Seems the new question is large pharma spending and how long that stays muted"
X Link 2023-08-04T12:55Z [----] followers, 12.8K engagements
"@LeveragedBunny Yeah my entire bioprocessing call is predicated on people positioning too short and then being forced to look past [----]. You can now make the same argument for $unh"
X Link 2023-08-04T13:15Z [----] followers, [--] engagements
"This vid makes me wanna manufacture drugs ASAP. JESSE WE NEED TO COOK $RGEN #Vimeo https://vimeo.com/787412981 https://vimeo.com/787412981"
X Link 2023-08-08T10:22Z [----] followers, [----] engagements
"Funding still coming back - we've now strung [--] "up" months together. Have seen conflicting data from other sell side firms but JEF seems to put actual effort into curating their screens. $DHR $TMO getting hungry to eat these dollars"
X Link 2023-08-08T13:52Z [----] followers, 12.4K engagements
"Big for science $CRL Charles Monkey has successfully mitigated the logistical challenges of the current NHP supply constraints. Raises the lower end of the guidance. Important datapoint for early stage biological research $CRL https://t.co/JvSXBwYuzZ Charles Monkey has successfully mitigated the logistical challenges of the current NHP supply constraints. Raises the lower end of the guidance. Important datapoint for early stage biological research $CRL https://t.co/JvSXBwYuzZ"
X Link 2023-08-09T13:03Z [----] followers, [----] engagements
"I know I joke about us being back a lot but I'm starting to think we're not actually back until $SYNH puts up a book-to-bill greater than [--]. Would tell you that the fragmented tail of cCROs are starting to see enough demand that $IQV $TMO $ICLR etc don't service Funding still coming back - we've now strung [--] "up" months together. Have seen conflicting data from other sell side firms but JEF seems to put actual effort into curating their screens. $DHR $TMO getting hungry to eat these dollars https://t.co/kx1MJFGtho Funding still coming back - we've now strung [--] "up" months together. Have seen"
X Link 2023-08-09T13:49Z [----] followers, [----] engagements
"On '24 numbers (P/S since they all burn dollars): $BLFS: 5x w/o biz assuming 0% growth on '23 $MXCT: 6-7x (w/ a high-80s/90% GM) 30% growth $CLPT: 5x '24 estimates 20% growth $MRVI: 14x EV/'24 EBITDA assumes 4% sales growth and much lower margins than historical"
X Link 2023-08-11T09:30Z [----] followers, [----] engagements
"Obviously you need to believe numbers. but for $BLFS and $MRVI the out-year growth assumption for good multiples looks like a joke. $MXCT $CLPT are both supported by drugs launching ( $VRTX has a drug that lifts $MXCT growth by like 10% if it does what MS is modeling)"
X Link 2023-08-11T09:32Z [----] followers, [----] engagements
"Most of large cap looks fully valued except for CROs and MCOs. $UNH $CRL $IQV $ICLR all cheap on multiples as does $EVT if you normalize a bit. Could argue $UNH and the other MCOs have some TV risk w/ GLP1s"
X Link 2023-08-11T09:35Z [----] followers, [----] engagements
"@mghanco If you believe the street estimates for both $IQV and $MEDP out to [----] they are equally cheap if you adjust for growth"
X Link 2023-08-11T10:57Z [----] followers, [---] engagements
"Finally got done w/ my poast (@Larryjamieson_ got me addicted to this spelling) on $RGEN talking about why I think it outgrows $DHR / $SRT / $TMO in bioprocessing while being a lot less expensive than meets the eye. You know where to find it. Haters gonna short anyway"
X Link 2023-08-11T13:24Z [----] followers, 14.5K engagements
"Fair bit of contrast between MCO and Tools analyst takes on $NVO $LLY obesity drugs. Both are optimistic but both probably can't right in the short-term. Left is BofA explaining why the insurance burden won't be huge to $UNH $CI $ELV etc because there are levers the MCOs (esp. those w/ PBMs) can pull to slow the rate at which they cover these drugs for obesity while they align plan pricing to the costs. Right is Stephens quantifying what the benefit of these drugs to $WST would be if 18% of all obese (all levels of severity) US adults 45+ were on it by [----] in a base case. That's a lot of"
X Link 2023-08-15T14:15Z [----] followers, 14K engagements
"@peter_mantas Actually scratch what I said. The molecule itself is "small" (not complex) but still delivered via mammalian cell. Totally gonna be a complex/biologics mfg process at scale"
X Link 2023-08-25T15:54Z [----] followers, [---] engagements
"$DHR for $ABCM is solid strategically IMO. I think a lot of people always thought $TECH would be the way Danaher gets into antibody production. Maybe takes some of the floor out from under their multiple. Speaking of multiple. 32x EBITDA is steep"
X Link 2023-08-28T12:50Z [----] followers, 10.6K engagements
"@RAMCOCAPITAL @PythiaR Overlap is super small. The $TECH team (about half of company is direct compare) is mostly ex Danaher and built theirs to not overlap as well. So if theres an issue it's gonna be a little less direct but I'd be surprised to see it"
X Link 2023-08-28T13:00Z [----] followers, [---] engagements
"@sinstockpapi @ComebackCap More about the t2 population which should shrink in theory (assuming mass adoption). I think $DXCM does fine for the next few years but the terminal value is definitely impacted for both"
X Link 2023-08-29T15:59Z [----] followers, [--] engagements
"I think $CTLT sandbagged the guide tbh"
X Link 2023-08-30T02:07Z [----] followers, [----] engagements
"@astridwilde1 $STVN if you think $WST is in that category"
X Link 2023-09-05T00:31Z [----] followers, [---] engagements
"$ILMN New CEO looks like a pragmatic fit coming from $A . Probably some more risk to topline numbers this year but considering refreshing the case on profitability post GRAIL alone"
X Link 2023-09-05T11:37Z [----] followers, [----] engagements
"@ZissouCapital It looks like mostly pens tbh. Not sure how much you need high end Nexa if I'm right"
X Link 2023-09-05T18:42Z [----] followers, [---] engagements
"@ZissouCapital Bottom line for me is that it's insane ppl are paying more for $WST than $STVN on '24 numbers. More rev upside margin upside etc for a 10% discount if you believe this is all gonna be injectable for a few years"
X Link 2023-09-05T18:54Z [----] followers, [---] engagements
"@LongVollllll I just dont know if anyone is gonna buy a word these companies say at MS. What even got cheap"
X Link 2023-09-06T12:43Z [----] followers, [---] engagements
"@sinstockpapi @Invesquotes None of them are perfectly sturdy IMO but $STVN if you believe injectables will be the most viable for [--] years"
X Link 2023-09-06T16:15Z [----] followers, [----] engagements
"@HeLaPapi @sinstockpapi @Invesquotes I think they missed the wave with the big ones but are trying to win all the pipeline products"
X Link 2023-09-06T17:55Z [----] followers, [---] engagements
"@HeLaPapi @hoosier_to @riceforthought @sinstockpapi @Invesquotes Kinda misses the point. you have to get diagnosed to get the GLPs for t2beetus so ofc you're gonna get scripted a CGM too since they run through the same channel. The real concern is what happens when ppl are getting GLP for obesity and many stop converting to the beetus"
X Link 2023-09-06T17:57Z [----] followers, [---] engagements
"@SriniKartik @HeLaPapi @hoosier_to @riceforthought @sinstockpapi @Invesquotes Depends I suppose. Do you stay on the drugs and endure the side effects forever or do you try to switch to the gym I think the consumer angle is going to be fascinating if waves are made"
X Link 2023-09-07T11:01Z [----] followers, [--] engagements
"@JerryCap @y2duggan @KathleenCa84658 We have preventative measures for obesity. $TDOC acquired one and it was an excellent short. Sam Im sorry you dont approve of how large pharmaceutical companies are trying to deal with the unsolved obesity problem 🙃"
X Link 2023-09-08T17:34Z [----] followers, [---] engagements
"@PythiaR They sounded bad this week on bp"
X Link 2023-09-08T18:52Z [----] followers, [----] engagements
"@valuebug @pekwat $IQV and $ICLR in clinical (more stable through cycle) $CRL and $EVT in pre-clinical (slightly more funding macro exposure)"
X Link 2023-09-11T14:36Z [----] followers, [---] engagements
"@TheNarrenschiff Glad it reads as intended 😤"
X Link 2023-09-12T20:14Z [----] followers, [---] engagements
"Based on the reactions I've heard from ppl talking to them at conferences the last couple of weeks and the contents of my prior tweet about how gene therapies are progressing way too slowly it's starting to seem likely $RGEN takes another guide cut next Q. Management might be getting blindsided on the slowness in gene therapy progression ( $CYRX release and $TECH AD have nuggets reinforcing this) after focusing intensely on figuring out what their exposures are to small biopharma broadly (via CDMOs) and navigating China forecast. CFO "retirement" doesn't help. Given exposure could be up to a"
X Link 2023-09-12T20:21Z [----] followers, 26.3K engagements
"@TheNarrenschiff This sounds like it doesnt go up and to the right. Are we compounding multiple contraction"
X Link 2023-11-06T23:39Z [----] followers, [---] engagements
"Is there a FAANG in life sciences Yes. It's called TRDS. Because they trade like them. For now. $TMO $RGEN $DHR $SRT"
X Link 2023-11-14T18:01Z [----] followers, 44.2K engagements
"The $XBI didnt bottom unless biotwitter has finally learned the difference between a research institute and a company"
X Link 2023-11-20T23:19Z [----] followers, [----] engagements
"Felt like I had a lot more to be thankful for this year than most. Pretty awesome feeling. Happy Thanksgiving fam"
X Link 2023-11-24T03:40Z [----] followers, [---] engagements
"Happy $UNH day to those who celebrate"
X Link 2023-11-29T12:54Z [----] followers, [----] engagements
"@callerycap Ill throw a venture capitalist at you"
X Link 2023-12-14T01:59Z [----] followers, [---] engagements
"@JerryCap Imagine getting hit with a tariff on an input you cant switch away from because you specified a Chinese supplier in your FDA filing lmao"
X Link 2023-12-27T14:04Z [----] followers, [---] engagements
"@princetongb Yeah I dont like paying for rent in dollar spot ETFs. Doesnt feel secure enough"
X Link 2024-01-05T02:47Z [--] followers, [---] engagements
"@valuebug @rev_cap @WallStCynic Healthcare component is mostly healthcare wages which were inflated by temp labor"
X Link 2024-01-13T16:02Z [----] followers, [---] engagements
"@peterphan88 @peter_mantas @LionelHutz_Esq It's a video game company actually"
X Link 2024-01-26T00:12Z [----] followers, [--] engagements
"Same. Ignoring stuff that doesn't trade at a large FCF yield because it isn't a "value stock" is silly. Value guys I've met do this (stay in low P/E) because they believe you can't forecast out years reliably so they assume it can't be done and pass on tons of excellent businesses. They also like the idea that low P/E has downside protection which is also proven false when P/E compresses even more than they think is fair. No excuse to rely so hard on this when you're a long/short fund and can just hedge multiple risks out. The reality is that even if you think one can't forecast growth the"
X Link 2024-02-08T14:01Z [----] followers, 61.4K engagements
"Agree but don't think that's really what is at the heart of the debate. It's about terminal value. Value guys buying cigar butts can't get paid on multiple if the market is only becoming more discerning/opinionated on terminal value which isn't really moving around much for their universe"
X Link 2024-02-08T18:58Z [----] followers, [---] engagements
"Bill Gates wishes he thought of this during his Microsoft hypebeast days"
X Link 2024-02-21T18:11Z [----] followers, [----] engagements
"What's the highest market cap you've ever seen a therapeutics company get to without a drug in phase [--] or commercial"
X Link 2024-02-22T20:33Z [----] followers, [----] engagements
"@TheNarrenschiff Whos the lucky one today"
X Link 2024-02-28T15:41Z [----] followers, [---] engagements
"@MihaiDoho @ftr_investors @EricFlaningam @DisruptorStocks @FedexSTi @ronjonbSaaS @LogicalThesis @SteadyCompound @GeneInvesting @FromValue @StockSavvyShay Needs more monkey prison"
X Link 2024-03-01T12:54Z [----] followers, [---] engagements
"@MihaiDoho @ftr_investors @EricFlaningam @DisruptorStocks @FedexSTi @ronjonbSaaS @LogicalThesis @SteadyCompound @GeneInvesting @FromValue @StockSavvyShay I will die on this hill. And so will all the monkeys at $35k+ a pop"
X Link 2024-03-01T13:07Z [----] followers, [--] engagements
"Long pharma services"
X Link 2024-03-06T01:07Z [----] followers, 15.6K engagements
"@BeachedCapital None tbh"
X Link 2024-03-06T02:08Z [----] followers, [---] engagements
"@NeoKJ2505 CRL LH NOTV in that order"
X Link 2024-03-06T02:26Z [----] followers, [---] engagements
"It's really not subjective. The illiquid stuff is on the balance sheet marked at the last round valuation. LT investments is 137M ST is 120M of which some is probably Sernova and EXAI which ties closely to my [---]. Do you have a view on one of the privates being much bigger in the future"
X Link 2024-03-15T16:03Z [----] followers, [---] engagements
"@SexyLikeMeiosis Because what could go wrong if you just make the bioreactor bigger"
X Link 2024-03-21T15:57Z [----] followers, [----] engagements
"@FelixSchreibe13 @peter_mantas Was talking about the last 4/6 trains. Saw in transcript old CEO said end of year implying they hit the brakes or something"
X Link 2024-03-22T13:48Z [----] followers, [--] engagements
"@WallStCynic @crazyjoedavola_ I am outraged You said number go up"
X Link 2024-04-10T01:22Z [----] followers, [---] engagements
"@LaissezFaire416 Just threaten to squat"
X Link 2024-04-11T20:42Z [----] followers, [--] engagements
"That's new. if true kind of a big deal/paradigm shift vs the last 5-7 years"
X Link 2024-04-16T19:14Z [----] followers, [----] engagements
"@B6203107361179 hahahahahahah wtf is this"
X Link 2024-04-23T11:48Z [----] followers, [---] engagements
"@TheLAPurchaser Dude yes. Monkey prisons. LFG"
X Link 2024-04-25T19:05Z [----] followers, [---] engagements
"@TheLAPurchaser Agree. Right now still pretty crowded short. think they beat on mfg this Q too"
X Link 2024-04-25T19:15Z [----] followers, [---] engagements
"@Goderguy @TheLAPurchaser Discovery chemistry is a big overlap between the two as well. Lead times on all that is 3-6 mo also iirc"
X Link 2024-04-27T02:11Z [----] followers, [---] engagements
"@LaissezFaire416 Fintwit will do anything to avoid being forced to compound lmao"
X Link 2024-05-17T20:37Z [----] followers, [--] engagements
"Candidly I am devastated at what happened today. Justice was not served. Politics should never come before the truth. My PM should have given my short rec its day in court but was ignored. And its not because of my atrocious hit rate"
X Link 2024-05-31T01:53Z [----] followers, [---] engagements
"Did anyone else notice X take the mute option off the For You feed Give it back"
X Link 2024-05-31T02:27Z [----] followers, [----] engagements
"@PetramcoC Dont love the TAS business but its gonna be more interesting when they re-launch their software w Salesforce later this year. Do love the trial business but have preferred ICON most of the year. Chuckie is most dislocated though"
X Link 2024-06-06T10:37Z [----] followers, [---] engagements
"It's a little silly how much confidence investors put behind big tools companies but avoid big CROs on macro despite the same drivers. I keep hearing pricing as a risk but then they raise price every year and take share at the same time. Valuation disparity still nuts"
X Link 2024-06-06T13:09Z [----] followers, [----] engagements
"@LongVollllll They should have gone out BEFORE ppl realized HC AI is all bs"
X Link 2024-06-15T15:35Z [----] followers, [---] engagements
"@TwistBioscience Centrifuge (duh)"
X Link 2024-07-11T16:19Z [----] followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/creator/twitter::Borlaug_